| Non-indicator text resource | CG1027 | | |
| Test Syndication - IFP | NG295 | | |
| MLB test IFP resource for syndication | NG296 | | |
| HTE temp withdrawn | HST120 | | |
| Temp Withdrawn Test | CG203 | | |
| Master test-639 | NG243 | | |
| Claire test | CG8923 | | |
| PUB602 pretest | NG242 | | |
| Master new feeds test | CG273 | | |
| NG Pdf test | NG275 | | |
| Test Product 554 | DG65 | | |
| Test Product 554 | CG272 | | |
| DG test -636 | DG92 | | |
| Test PUB636 | CG200 | | |
| PUB550 test | CG279 | | |
| PUB550 test | CG197 | | |
| DG Content Order test | DG95 | | |
| Content Order test | CG199 | | |
| Master test-552 | DG91 | | |
| PUB-552 test | DG90 | | |
| Master Pub test | CG195 | | |
| Conversion word test | CG194 | | |
| PUB-545 Resource Type test | DG59 | | |
| Minimally invasive percutaneous surgical techniques with internal fixation for correcting hallux valgus | IPG789 | | |
| Tafamidis for treating transthyretin amyloidosis with cardiomyopathy | TA984 | | |
| Baricitinib for treating juvenile idiopathic arthritis in people 2 years and over (terminated appraisal) | TA982 | | |
| Pembrolizumab with trastuzumab and chemotherapy for untreated locally advanced unresectable or metastatic HER2-positive gastric or gastro-oesophageal junction adenocarcinoma | TA983 | | |
| Voxelotor for treating haemolytic anaemia caused by sickle cell disease | TA981 | | |
| Nivolumab for adjuvant treatment of completely resected melanoma at high risk of recurrence in people 12 years and over (terminated appraisal) | TA980 | | |
| Ivosidenib with azacitidine for untreated acute myeloid leukaemia with an IDH1 R132 mutation | TA979 | | |
| Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments (terminated appraisal) | TA978 | | |
| Dabrafenib with trametinib for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over | TA977 | | |
| Trastuzumab deruxtecan for treating HER2-mutated advanced non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal) | TA976 | | |
| Sirolimus for treating facial angiofibroma caused by tuberous sclerosis complex in people 6 years and over (terminated appraisal) | TA972 | | |
| Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome | HST31 | | |
| Cladribine for treating relapsing–remitting multiple sclerosis | TA616 | | |
| Alemtuzumab for treating highly active relapsing–remitting multiple sclerosis | TA312 | | |
| Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis | TA127 | | |
| Ranibizumab for treating choroidal neovascularisation associated with pathological myopia | TA298 | | |
| Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion | TA283 | | |
| Ranibizumab and pegaptanib for the treatment of age-related macular degeneration | TA155 | | |
| Image-guided percutaneous laser ablation for primary and secondary liver tumours | IPG788 | | |
| Endoscopic duodenal mucosal resurfacing for insulin resistance in type 2 diabetes | IPG787 | | |
| Selective internal radiation therapy for neuroendocrine tumours that have metastasised to the liver | IPG786 | | |
| Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and under | TA975 | | |
| Selinexor with bortezomib and dexamethasone for previously treated multiple myeloma | TA974 | | |
| Atogepant for preventing migraine | TA973 | | |
| Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer | DG58 | | |
| Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 | TA971 | | |
| Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments | TA970 | | |
| COVID-19 rapid guideline: managing COVID-19 | NG191 | | |
| Artificial intelligence (AI)-derived software to help clinical decision making in stroke | DG57 | | |
| Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and over | TA967 | | |
| Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma | TA540 | | |
| Gefapixant for treating refractory or unexplained chronic cough (terminated appraisal) | TA969 | | |
| Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment | HTE18 | | |
| Melphalan flufenamide with dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA968 | | |
| Pembrolizumab with gemcitabine and cisplatin for untreated advanced biliary tract cancer (terminated appraisal) | TA966 | | |
| Endometriosis: diagnosis and management | NG73 | | |
| Lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema | IPG785 | | |
| Cabozantinib with nivolumab for untreated advanced renal cell carcinoma | TA964 | | |
| Twin and triplet pregnancy | NG137 | | |
| Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency | TA963 | | |
| GaitSmart rehabilitation exercise programme for gait and mobility issues | MTG78 | | |
| Kurin Lock for blood culture collection | MTG77 | | |
| Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancer | IPG784 | | |
| Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal) | TA965 | | |
| Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy | TA962 | | |
| Sebelipase alfa for treating lysosomal acid lipase deficiency that is not Wolman disease (terminated appraisal) | TA961 | | |
| Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal) | TA960 | | |
| Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis | TA959 | | |
| Ritlecitinib for treating severe alopecia areata in people 12 years and over | TA958 | | |
| Desflurane for maintenance of anaesthesia | ES41 | | |
| Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessment | HTE17 | | |
| Ovarian cancer: identifying and managing familial and genetic risk | NG241 | | |
| Momelotinib for treating myelofibrosis-related splenomegaly or symptoms | TA957 | | |
| Neonatal infection: antibiotics for prevention and treatment | NG195 | | |
| Suspected sepsis: recognition, diagnosis and early management | NG51 | | |
| Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management | NG240 | | |
| ProKnow cloud-based system for radiotherapy data storage, communication and management: early value assessment | HTE5 | | |
| Dupilumab for treating moderate to severe prurigo nodularis | TA955 | | |
| Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema | TA953 | | |
| Nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19 | TA878 | | |
| Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and over | TA956 | | |
| Lung cancer: diagnosis and management | NG122 | | |
| Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments | TA954 | | |
| Vitamin B12 deficiency in over 16s: diagnosis and management | NG239 | | |
| Digital technologies for delivering multidisciplinary weight-management services: early value assessment | HTE14 | | |
| Digital technologies for managing non-specific low back pain: early value assessment | HTE16 | | |
| Endoscopic sleeve gastroplasty for obesity | IPG783 | | |
| Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations | TA952 | | |
| Tuberculosis | NG33 | | |
| Digitally enabled therapies for adults with depression: early value assessment | HTE8 | | |
| Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer | TA951 | | |
| Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over | TA950 | | |
| Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over | TA949 | | |
| Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments | TA948 | | |
| Loncastuximab tesirine for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma after 2 or more systemic treatments | TA947 | | |
| Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal) | TA945 | | |
| Caesarean birth | NG192 | | |
| COVID-19 rapid guideline: managing the long-term effects of COVID-19 | NG188 | | |
| Devices for remote monitoring of Parkinson's disease | DG51 | | |
| Skin cancer | QS130 | | |
| Neonatal infection | QS75 | | |
| Temperature control to improve neurological outcomes after cardiac arrest | IPG782 | | |
| Pharyngeal electrical stimulation for neurogenic dysphagia | IPG781 | | |
| Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer | TA946 | | |
| Early and locally advanced breast cancer: diagnosis and management | NG101 | | |
| Durvalumab with gemcitabine and cisplatin for treating unresectable or advanced biliary tract cancer | TA944 | | |
| Sebelipase alfa for treating Wolman disease | HST30 | | |
| Intravascular lithotripsy for calcified arteries in peripheral arterial disease | IPG780 | | |
| Bipolar disorder: assessment and management | CG185 | | |
| Empagliflozin for treating chronic kidney disease | TA942 | | |
| Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal) | TA941 | | |
| Ravulizumab for treating generalised myasthenia gravis (terminated appraisal) | TA940 | | |
| Targeted-release budesonide for treating primary IgA nephropathy | TA937 | | |
| Epilepsies in children, young people and adults | QS211 | | |
| Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes | TA943 | | |
| Risdiplam for treating spinal muscular atrophy | TA755 | | |
| Transition from children's to adults' services | QS140 | | |
| Cardiovascular disease: risk assessment and reduction, including lipid modification | NG238 | | |
| Middle meningeal artery embolisation for chronic subdural haematomas | IPG779 | | |
| Digitally enabled therapies for adults with anxiety disorders: early value assessment | HTE9 | | |
| Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer | TA939 | | |
| Velmanase alfa for treating alpha-mannosidosis | HST29 | | |
| Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal) | TA938 | | |
| Acne vulgaris: management | NG198 | | |
| Secukinumab for treating moderate to severe hidradenitis suppurativa | TA935 | | |
| Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal) | TA936 | | |
| Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptoms | TA934 | | |
| Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal) | TA933 | | |
| Percutaneous thrombectomy for intermediate-risk or high-risk pulmonary embolism | IPG778 | | |
| Decitabine–cedazuridine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable (terminated appraisal) | TA932 | | |
| Zanubrutinib for treating chronic lymphocytic leukaemia | TA931 | | |
| Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis | IPG777 | | |
| Hypertension in adults: diagnosis and management | NG136 | | |
| Transient loss of consciousness ('blackouts') in over 16s | CG109 | | |
| Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management | NG237 | | |
| Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatments | TA930 | | |
| Extracorporeal carbon dioxide removal for acute respiratory failure | IPG776 | | |
| Biodegradable subacromial spacer insertion for rotator cuff tears | IPG775 | | |
| Virtual reality technologies for treating agoraphobia or agoraphobic avoidance: early value assessment | HTE15 | | |
| Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | CG164 | | |
| Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction | TA929 | | |
| Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine | TA928 | | |
| Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home) | QS210 | | |
| Jaundice in newborn babies under 28 days | CG98 | | |
| Pneumonia in adults: diagnosis and management | CG191 | | |
| Ranibizumab for treating diabetic macular oedema | TA274 | | |
| Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable | TA917 | | |
| Baricitinib for treating severe alopecia areata | TA926 | | |
| Mirikizumab for treating moderately to severely active ulcerative colitis | TA925 | | |
| Tirzepatide for treating type 2 diabetes | TA924 | | |
| Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions | IPG774 | | |
| Tabelecleucel for treating post-transplant lymphoproliferative disorder caused by the Epstein-Barr virus (terminated appraisal) | TA923 | | |
| Daridorexant for treating long-term insomnia | TA922 | | |
| Ruxolitinib for treating polycythaemia vera | TA921 | | |
| Tofacitinib for treating active ankylosing spondylitis | TA920 | | |
| Rimegepant for treating migraine | TA919 | | |
| Stroke rehabilitation in adults | NG236 | | |
| Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia | IPG773 | | |
| Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments | TA927 | | |
| Thyroid disease: assessment and management | NG145 | | |
| Virtual ward platform technologies for acute respiratory infections | HTE13 | | |
| Bimekizumab for treating axial spondyloarthritis | TA918 | | |
| Bimekizumab for treating active psoriatic arthritis | TA916 | | |
| Pegunigalsidase alfa for treating Fabry disease | TA915 | | |
| Hearing loss in adults: assessment and management | NG98 | | |
| Suspected cancer: recognition and referral | NG12 | | |
| Suspected neurological conditions: recognition and referral | NG127 | | |
| Urinary incontinence in neurological disease: assessment and management | CG148 | | |
| Ovarian cancer: recognition and initial management | CG122 | | |
| Intrapartum care | NG235 | | |
| COVID-19 rapid guideline: haematopoietic stem cell transplantation | NG164 | | |
| Acute kidney injury: prevention, detection and management | NG148 | | |
| Artificial intelligence-derived software to analyse chest X-rays for suspected lung cancer in primary care referrals: early value assessment | HTE12 | | |
| Artificial intelligence technologies to aid contouring for radiotherapy treatment planning: early value assessment | HTE11 | | |
| KardiaMobile 6L for measuring cardiac QT interval in adults having antipsychotic medication | HTE10 | | |
| Removal, preservation and reimplantation of ovarian tissue for restoring fertility after gonadotoxic treatment | IPG772 | | |
| Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency | TA914 | | |
| Birch bark extract for treating epidermolysis bullosa | HST28 | | |
| Chronic obstructive pulmonary disease in adults | QS10 | | |
| Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia | IPG770 | | |
| Cryotherapy for chronic rhinitis | IPG771 | | |
| Cirrhosis in over 16s: assessment and management | NG50 | | |
| Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy | TA913 | | |
| Spinal metastases and metastatic spinal cord compression | QS56 | | |
| Spinal metastases and metastatic spinal cord compression | NG234 | | |
| Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment | HTE3 | | |
| Semaglutide for managing overweight and obesity | TA875 | | |
| Otitis media with effusion in under 12s | NG233 | | |
| Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | DG56 | | |
| Ectopic pregnancy and miscarriage: diagnosis and initial management | NG126 | | |
| Cipaglucosidase alfa with miglustat for treating late-onset Pompe disease | TA912 | | |
| Genedrive MT-RNR1 ID Kit for detecting a genetic variant to guide antibiotic use and prevent hearing loss in babies: early value assessment | HTE6 | | |
| Aortic valve reconstruction with glutaraldehyde-treated autologous pericardium for aortic valve disease | IPG769 | | |
| Venous thromboembolic diseases: diagnosis, management and thrombophilia testing | NG158 | | |
| Selpercatinib for untreated RET fusion-positive advanced non-small-cell lung cancer | TA911 | | |
| Afamelanotide for treating erythropoietic protoporphyria | HST27 | | |
| Obesity: identification, assessment and management | CG189 | | |
| KardiaMobile for detecting atrial fibrillation | MTG64 | | |
| Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal) | TA910 | | |
| Lorlatinib for untreated ALK-positive advanced non-small-cell lung cancer | TA909 | | |
| Alcohol-use disorders: diagnosis and management | QS11 | | |
| Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy | TA908 | | |
| Rimegepant for preventing migraine | TA906 | | |
| Irreversible electroporation for treating prostate cancer | IPG768 | | |
| AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images | DG55 | | |
| Oesophago-gastric cancer: assessment and management in adults | NG83 | | |
| Depression in adults | QS8 | | |
| Deucravacitinib for treating moderate to severe plaque psoriasis | TA907 | | |
| Radiofrequency denervation for osteoarthritic knee pain | IPG767 | | |
| Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention | IPG766 | | |
| Minimally invasive fusionless posterior-approach surgery to correct idiopathic scoliosis in children and young people | IPG765 | | |
| Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an option | IPG764 | | |
| Upadacitinib for previously treated moderately to severely active Crohn's disease | TA905 | | |
| Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer | TA904 | | |
| Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer | TA903 | | |
| Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction | TA902 | | |
| Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal) | TA901 | | |
| MiraQ cardiac TTFM with high-frequency probe for assessing graft flow during coronary artery bypass graft surgery | MIB323 | | |
| Tixagevimab plus cilgavimab for preventing COVID-19 | TA900 | | |
| Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer | TA898 | | |
| YOURmeds for medication support in long-term conditions | MIB289 | | |
| Bulevirtide for treating chronic hepatitis D | TA896 | | |
| Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy | TA895 | | |
| Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma | TA894 | | |
| Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over | TA893 | | |
| FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care | DG48 | | |
| Atopic eczema in under 12s: diagnosis and management | CG57 | | |
| Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal) | TA899 | | |
| Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma | TA897 | | |
| Proov Confirm for ovulation confirmation | MIB322 | | |
| Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancer | IPG763 | | |
| Transperineal biopsy for diagnosing prostate cancer | DG54 | | |
| Mosunetuzumab for treating relapsed or refractory follicular lymphoma | TA892 | | |
| Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia | TA891 | | |
| Cardiovascular risk assessment and lipid modification | QS100 | | |
| Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries | IPG762 | | |
| MRI fusion biopsy systems for diagnosing prostate cancer | DG53 | | |
| Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers | DG52 | | |
| Head injury | QS74 | | |
| Head injury: assessment and early management | NG232 | | |
| Difelikefalin for treating pruritus in people having haemodialysis | TA890 | | |
| Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA889 | | |
| Risankizumab for previously treated moderately to severely active Crohn's disease | TA888 | | |
| Diabetes (type 1 and type 2) in children and young people: diagnosis and management | NG18 | | |
| Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer | TA887 | | |
| Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy | TA886 | | |
| Point-of-care tests for urinary tract infections to improve antimicrobial prescribing: early value assessment | HTE7 | | |
| Capmatinib for treating advanced non-small-cell lung cancer with MET exon 14 skipping (terminated appraisal) | TA884 | | |
| Tafasitamab with lenalidomide for treating relapsed or refractory diffuse large B-cell lymphoma | TA883 | | |
| Voclosporin with mycophenolate mofetil for treating lupus nephritis | TA882 | | |
| Ripretinib for treating advanced gastrointestinal stromal tumour after 3 or more treatments | TA881 | | |
| Metastatic malignant disease of unknown primary origin in adults: diagnosis and management | CG104 | | |
| Fasciotens for abdominal wall closure | MIB321 | | |
| Tezepelumab for treating severe asthma | TA880 | | |
| Endoscopic ultrasound-guided biliary drainage for biliary obstruction | IPG761 | | |
| Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoea | IPG760 | | |
| Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency | HST26 | | |
| Lumasiran for treating primary hyperoxaluria type 1 | HST25 | | |
| Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy | HST24 | | |
| Onasemnogene abeparvovec for treating spinal muscular atrophy | HST15 | | |
| Hypertension in pregnancy: diagnosis and management | NG133 | | |
| AposHealth for knee osteoarthritis | MTG76 | | |
| Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal) | TA879 | | |
| Focal therapy using high-intensity focused ultrasound for localised prostate cancer | IPG756 | | |
| Percutaneous thoracic duct embolisation for persistent chyle leak | IPG755 | | |
| Radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastases | IPG759 | | |
| Radiofrequency ablation for palliation of painful spinal metastases | IPG758 | | |
| Maximal cytoreductive surgery for advanced ovarian cancer | IPG757 | | |
| UrgoStart for treating diabetic foot ulcers and leg ulcers | MTG42 | | |
| Macimorelin for diagnosing growth hormone deficiency | MIB320 | | |
| Finerenone for treating chronic kidney disease in type 2 diabetes | TA877 | | |
| Acute kidney injury | QS76 | | |
| Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer | TA876 | | |
| CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessment | HTE4 | | |
| QbTest for the assessment of attention deficit hyperactivity disorder (ADHD) | MIB318 | | |
| Type 2 diabetes in adults | QS209 | | |
| Type 1 diabetes in adults | QS208 | | |
| Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma | TA874 | | |
| Cannabidiol for treating seizures caused by tuberous sclerosis complex | TA873 | | |
| Eptinezumab for preventing migraine | TA871 | | |
| Percutaneous transluminal renal sympathetic denervation for resistant hypertension | IPG754 | | |
| Endoluminal gastroplication for gastro-oesophageal reflux disease | IPG753 | | |
| Asfotase alfa for treating paediatric-onset hypophosphatasia | HST23 | | |
| Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies | TA872 | | |
| Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma | TA870 | | |
| Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene | HST22 | | |
| LIVERFASt for assessing and monitoring liver fibrosis, activity and steatosis | MIB317 | | |
| Teclistamab for treating relapsed or refractory multiple myeloma after 3 or more therapies (terminated appraisal) | TA869 | | |
| Mitapivat for treating pyruvate kinase deficiency (terminated appraisal) | TA867 | | |
| Vutrisiran for treating hereditary transthyretin-related amyloidosis | TA868 | | |
| Urinary tract infections in adults | QS90 | | |
| Antenatal care | QS22 | | |
| Ambu aScope 4 RhinoLaryngo for visualising upper airways during rhinolaryngoscopy | MIB316 | | |
| Regorafenib for previously treated metastatic colorectal cancer | TA866 | | |
| Nivolumab with fluoropyrimidine- and platinum-based chemotherapy for untreated unresectable advanced, recurrent, or metastatic oesophageal squamous cell carcinoma | TA865 | | |
| Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management | NG231 | | |
| Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer | IPG752 | | |
| Transvenous obliteration for gastric varices | IPG751 | | |
| Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted | TA864 | | |
| Somatrogon for treating growth disturbance in children and young people aged 3 years and over | TA863 | | |
| Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments | TA862 | | |
| Upadacitinib for treating active non-radiographic axial spondyloarthritis | TA861 | | |
| Aquablation robotic therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia | MIB315 | | |
| Maribavir for treating refractory cytomegalovirus infection after transplant | TA860 | | |
| Delirium: prevention, diagnosis and management in hospital and long-term care | CG103 | | |
| Ambu aScope 4 Broncho for routine diagnostic and therapeutic bronchoscopy | MIB314 | | |
| Trabeculectomy with a biodegradable collagen matrix implant for glaucoma | IPG750 | | |
| Angiotensin II for treating vasosuppressor-resistant hypotension caused by septic or distributive shock (terminated appraisal) | TA859 | | |
| Tobacco: preventing uptake, promoting quitting and treating dependence | NG209 | | |
| Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education | NG213 | | |
| MRI-based technologies for assessing non-alcoholic fatty liver disease | DG50 | | |
| Lenvatinib with pembrolizumab for untreated advanced renal cell carcinoma | TA858 | | |
| Nivolumab with platinum- and fluoropyrimidine-based chemotherapy for untreated HER2-negative advanced gastric, gastro-oesophageal junction or oesophageal adenocarcinoma | TA857 | | |
| Laparoscopic insertion of a magnetic ring for gastro-oesophageal reflux disease | IPG749 | | |
| Transcutaneous electrical stimulation of the trigeminal nerve for ADHD | IPG748 | | |
| Chronic heart failure in adults | QS9 | | |
| Diabetes in pregnancy | QS109 | | |
| PredictSURE IBD for inflammatory bowel disease prognosis: ulcerative colitis | MIB313 | | |
| Hip fracture in adults | QS16 | | |
| Hip fracture: management | CG124 | | |
| Upadacitinib for treating moderately to severely active ulcerative colitis | TA856 | | |
| Percutaneous image-guided cryoablation of peripheral neuroma for chronic pain | IPG747 | | |
| Thyroid cancer: assessment and management | NG230 | | |
| Avatrombopag for treating primary chronic immune thrombocytopenia | TA853 | | |
| Tobacco: treating dependence | QS207 | | |
| Esketamine nasal spray for treatment-resistant depression | TA854 | | |
| Trifluridine–tipiracil for treating metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma after 2 or more treatments | TA852 | | |
| Pembrolizumab for neoadjuvant and adjuvant treatment of triple-negative early or locally advanced breast cancer | TA851 | | |
| Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy | TA850 | | |
| Cabozantinib for previously treated advanced hepatocellular carcinoma | TA849 | | |
| Fetal monitoring in labour | NG229 | | |
| PromarkerD for predicting the risk of diabetic kidney disease in people with type 2 diabetes | MIB312 | | |
| Memokath 051 Ureter stent for ureteric obstruction | MTG75 | | |
| Cemiplimab for untreated PD-L1-positive advanced or metastatic non-small-cell lung cancer (terminated appraisal) | TA848 | | |
| Mepolizumab for treating severe chronic rhinosinusitis with nasal polyps (terminated appraisal) | TA847 | | |
| Mepolizumab for treating severe hypereosinophilic syndrome (terminated appraisal) | TA846 | | |
| Mepolizumab for treating eosinophilic granulomatosis with polyangiitis (terminated appraisal) | TA845 | | |
| GreenLight XPS for treating benign prostatic hyperplasia | MTG74 | | |
| Optilume for treating recurrent bulbar urethral strictures | MTG73 | | |
| Luspatercept for treating anaemia caused by myelodysplastic syndromes (terminated appraisal) | TA844 | | |
| Luspatercept for treating anaemia caused by beta-thalassaemia (terminated appraisal) | TA843 | | |
| Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management | NG228 | | |
| Fractures (complex): assessment and management | NG37 | | |
| Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosis | IPG746 | | |
| Tisagenlecleucel for treating follicular lymphoma after 2 or more therapies (terminated appraisal) | TA842 | | |
| Carfilzomib with daratumumab and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA841 | | |
| Ab interno canaloplasty for open-angle glaucoma | IPG745 | | |
| Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids
(terminated appraisal) | TA840 | | |
| Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal) | TA839 | | |
| Percutaneous ultrasound-guided microwave ablation for symptomatic benign thyroid nodules | IPG743 | | |
| Advocacy services for adults with health and social care needs | NG227 | | |
| Extracorporeal shockwave therapy for calcific tendinopathy in the shoulder | IPG742 | | |
| Slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis (terminated appraisal) | TA838 | | |
| Digital technologies for the detection of melanoma | MIB311 | | |
| Pembrolizumab for adjuvant treatment of resected stage 2B or 2C melanoma | TA837 | | |
| Palbociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy | TA836 | | |
| Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine | IPG740 | | |
| YAG laser vitreolysis for symptomatic vitreous floaters | IPG741 | | |
| Fostamatinib for treating refractory chronic immune thrombocytopenia | TA835 | | |
| Zanubrutinib for treating Waldenstrom's macroglobulinaemia | TA833 | | |
| Relugolix–estradiol–norethisterone acetate for treating moderate to severe symptoms of uterine fibroids | TA832 | | |
| Pembrolizumab for adjuvant treatment of renal cell carcinoma | TA830 | | |
| Osteoarthritis in over 16s | QS87 | | |
| Osteoarthritis in over 16s: diagnosis and management | NG226 | | |
| SQ HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (terminated appraisal) | TA834 | | |
| O2matic PRO 100 for optimising oxygen treatment in respiratory conditions | MIB308 | | |
| Ozanimod for treating moderately to severely active ulcerative colitis | TA828 | | |
| Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy | TA827 | | |
| Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer | MTG72 | | |
| Signatera for detecting molecular residual disease from solid tumour cancers | MIB307 | | |
| Upadacitinib for treating active ankylosing spondylitis | TA829 | | |
| Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer | TA823 | | |
| Postnatal care | QS37 | | |
| Neurostimulation of lumbar muscles for refractory non-specific chronic low back pain | IPG739 | | |
| Vedolizumab for treating chronic refractory pouchitis after surgery for ulcerative colitis (terminated appraisal) | TA826 | | |
| Avacopan for treating severe active granulomatosis with polyangiitis or microscopic polyangiitis | TA825 | | |
| Neuropad for detecting preclinical diabetic peripheral neuropathy | MTG38 | | |
| iTind for lower urinary tract symptoms caused by benign prostatic hyperplasia | MIB306 | | |
| Removal, preservation and subsequent reimplantation of ovarian tissue to prevent symptoms from the menopause | IPG738 | | |
| Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia | IPG737 | | |
| Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas | CG118 | | |
| Dexamethasone intravitreal implant for treating diabetic macular oedema | TA824 | | |
| Melphalan for haematological diseases before allogeneic haematopoietic stem cell transplant (terminated appraisal) | TA822 | | |
| Self‑harm | QS34 | | |
| Self-harm: assessment, management and preventing recurrence | NG225 | | |
| Brolucizumab for treating diabetic macular oedema | TA820 | | |
| Faecal microbiota transplant for recurrent Clostridioides difficile infection | MTG71 | | |
| iFuse for treating chronic sacroiliac joint pain | MTG39 | | |
| Differential target multiplexed spinal cord stimulation for chronic lower back and leg pain | MIB305 | | |
| Contrast-enhanced spectral mammography for breast cancer | MIB304 | | |
| Avalglucosidase alfa for treating Pompe disease | TA821 | | |
| Superficial venous arterialisation for chronic limb threatening ischaemia | IPG736 | | |
| Transcutaneous electrical neuromuscular stimulation for urinary incontinence | IPG735 | | |
| Focal resurfacing implants to treat articular cartilage damage in the knee | IPG734 | | |
| Sacituzumab govitecan for treating unresectable triple-negative advanced breast cancer after 2 or more therapies | TA819 | | |
| Nivolumab with ipilimumab for untreated unresectable malignant pleural mesothelioma | TA818 | | |
| Type 1 diabetes in adults: diagnosis and management | NG17 | | |
| Cefiderocol for treating severe drug-resistant gram-negative bacterial infections | HTE2 | | |
| Ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections | HTE1 | | |
| Nivolumab for adjuvant treatment of invasive urothelial cancer at high risk of recurrence | TA817 | | |
| Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer | TA816 | | |
| Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs | TA815 | | |
| SecurAcath for securing percutaneous catheters | MTG34 | | |
| Stockholm3 for prostate cancer screening | MIB303 | | |
| Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitis | TA814 | | |
| Asciminib for treating chronic myeloid leukaemia after 2 or more tyrosine kinase inhibitors | TA813 | | |
| Pralsetinib for treating RET fusion-positive advanced non-small-cell lung cancer | TA812 | | |
| Aortic remodelling hybrid stent insertion during surgical repair of an acute type A aortic dissection | IPG733 | | |
| Bioresorbable stent implantation to treat coronary artery disease | IPG732 | | |
| Duvelisib for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal) | TA811 | | |
| Fever in under 5s | QS64 | | |
| Urinary tract infection in children and young people | QS36 | | |
| Urinary tract infection in under 16s: diagnosis and management | NG224 | | |
| Melanoma: assessment and management | NG14 | | |
| Transcatheter tricuspid valve leaflet repair for tricuspid regurgitation | IPG731 | | |
| Transcatheter tricuspid valve annuloplasty for tricuspid regurgitation | IPG730 | | |
| PLGF-based testing to help diagnose suspected preterm pre-eclampsia | DG49 | | |
| Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence | TA810 | | |
| Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease | TA809 | | |
| PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites | MTG9 | | |
| Roxadustat for treating symptomatic anaemia in chronic kidney disease | TA807 | | |
| Belimumab for treating lupus nephritis (terminated appraisal) | TA806 | | |
| Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides | TA805 | | |
| Risankizumab for treating active psoriatic arthritis after inadequate response to DMARDs | TA803 | | |
| ProciseDx point-of-care platform for inflammatory bowel disease | MIB302 | | |
| Fenfluramine for treating seizures associated with Dravet syndrome | TA808 | | |
| Social, emotional and mental wellbeing in primary and secondary education | NG223 | | |
| Setmelanotide for treating obesity caused by LEPR or POMC deficiency | HST21 | | |
| MiraQ for assessing graft flow during coronary artery bypass graft surgery | MTG8 | | |
| Cyanoacrylate glue for hernia mesh fixation | MIB301 | | |
| Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease | MIB300 | | |
| RespiraSense for continuously monitoring respiratory rate | MIB299 | | |
| Teduglutide for treating short bowel syndrome | TA804 | | |
| Cemiplimab for treating advanced cutaneous squamous cell carcinoma | TA802 | | |
| Pembrolizumab plus chemotherapy for untreated, triple-negative, locally recurrent unresectable or metastatic breast cancer | TA801 | | |
| Faricimab for treating wet age-related macular degeneration | TA800 | | |
| Faricimab for treating diabetic macular oedema | TA799 | | |
| Depression in adults: treatment and management | NG222 | | |
| Type 2 diabetes in adults: management | NG28 | | |
| Nerve graft for corneal denervation | IPG729 | | |
| Vertebral body tethering for idiopathic scoliosis in children and young people | IPG728 | | |
| Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based chemoradiation | TA798 | | |
| Multiple sclerosis in adults: management | NG220 | | |
| Enfortumab vedotin for previously treated locally advanced or metastatic urothelial cancer (terminated appraisal) | TA797 | | |
| Venetoclax for treating chronic lymphocytic leukaemia | TA796 | | |
| Reducing sexually transmitted infections | NG221 | | |
| Preterm labour and birth | NG25 | | |
| Gout: diagnosis and management | NG219 | | |
| Ibrutinib for treating Waldenstrom's macroglobulinaemia | TA795 | | |
| Diroximel fumarate for treating relapsing–remitting multiple sclerosis | TA794 | | |
| Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal) | TA793 | | |
| Thopaz+ portable digital system for managing chest drains | MTG37 | | |
| Peristeen Plus transanal irrigation system for managing bowel dysfunction | MTG36 | | |
| Filgotinib for treating moderately to severely active ulcerative colitis | TA792 | | |
| Synthetic cartilage implant insertion for first metatarsophalangeal joint osteoarthritis (hallux rigidus) | IPG727 | | |
| TriageHF Plus for remotely monitoring people with cardiac implantable electronic devices at risk of heart failure or worsening heart failure | MIB298 | | |
| Social work with adults experiencing complex needs | NG216 | | |
| Romosozumab for treating severe osteoporosis | TA791 | | |
| TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal) | TA790 | | |
| Endoanchoring systems in endovascular aortic aneurysm repair | IPG725 | | |
| Supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis | IPG726 | | |
| Sleepio to treat insomnia and insomnia symptoms | MTG70 | | |
| Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations | TA789 | | |
| Personalised external aortic root support (PEARS) using mesh to prevent aortic root expansion and aortic dissection in people with Marfan syndrome | IPG724 | | |
| Vaccine uptake in under 19s | QS145 | | |
| Vaccine uptake in the general population | NG218 | | |
| Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy | TA788 | | |
| Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections | ES39 | | |
| Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adults | ES40 | | |
| Granulox for managing chronic non-healing wounds | MIB296 | | |
| ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions | MIB295 | | |
| AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomas | MIB294 | | |
| Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over | HST20 | | |
| Bladder EpiCheck for detecting bladder cancer recurrence | MIB293 | | |
| Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable | TA787 | | |
| Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies | TA786 | | |
| Epilepsies in children, young people and adults | NG217 | | |
| Liposuction for chronic lymphoedema | IPG723 | | |
| Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal) | TA785 | | |
| Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer | TA784 | | |
| Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults | NG215 | | |
| Intramedullary distraction for upper limb lengthening | IPG722 | | |
| Elosulfase alfa for treating mucopolysaccharidosis type 4A | HST19 | | |
| Daratumumab monotherapy for treating relapsed and refractory multiple myeloma | TA783 | | |
| Stroke and transient ischaemic attack in over 16s: diagnosis and initial management | NG128 | | |
| Diabetes in children and young people | QS125 | | |
| UroShield for preventing catheter-associated urinary tract infections | MTG69 | | |
| myCOPD for managing chronic obstructive pulmonary disease | MTG68 | | |
| Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal) | TA782 | | |
| Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer | TA781 | | |
| Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) | DG47 | | |
| Joint replacement (primary): hip, knee and shoulder | QS206 | | |
| icobrain ms for active relapsing–remitting multiple sclerosis | MIB291 | | |
| Liposuction for chronic lipoedema | IPG721 | | |
| Atidarsagene autotemcel for treating metachromatic leukodystrophy | HST18 | | |
| Nivolumab with ipilimumab for untreated advanced renal cell carcinoma | TA780 | | |
| Neonatal parenteral nutrition | QS205 | | |
| Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency | TA779 | | |
| Fetal alcohol spectrum disorder | QS204 | | |
| Integrated health and social care for people experiencing homelessness | NG214 | | |
| SecurePort IV tissue adhesive for use with percutaneous catheters | MIB288 | | |
| Otitis media (acute): antimicrobial prescribing | NG91 | | |
| Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria | TA778 | | |
| Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea | TA777 | | |
| Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea | TA776 | | |
| Dapagliflozin for treating chronic kidney disease | TA775 | | |
| Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal) | TA774 | | |
| Empagliflozin for treating chronic heart failure with reduced ejection fraction | TA773 | | |
| Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis | IPG720 | | |
| Prontosan for treating acute and chronic wounds | MTG67 | | |
| 3C Patch for treating diabetic foot ulcers | MTG66 | | |
| Mental wellbeing at work | NG212 | | |
| Endoscopic balloon dilation for subglottic or tracheal stenosis | IPG719 | | |
| Intramedullary distraction for lower limb lengthening | IPG718 | | |
| Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomach | IPG717 | | |
| Lumella point-of-care test for assessing pre-eclampsia risk | MIB287 | | |
| Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies | TA772 | | |
| EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules | DG46 | | |
| PredictSURE IBD and IBDX to guide treatment of Crohn's disease | DG45 | | |
| Odevixibat for treating progressive familial intrahepatic cholestasis | HST17 | | |
| The Insides System for managing intestinal failure | MIB286 | | |
| Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal) | TA771 | | |
| Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer | TA770 | | |
| d-Nav insulin management app for type 2 diabetes | MIB285 | | |
| Palforzia for treating peanut allergy in children and young people | TA769 | | |
| Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs | TA768 | | |
| Ponesimod for treating relapsing–remitting multiple sclerosis | TA767 | | |
| Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma | TA766 | | |
| Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable | TA765 | | |
| Fremanezumab for preventing migraine | TA764 | | |
| Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable | TA763 | | |
| Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal) | TA762 | | |
| Microwave ablation for primary or metastatic cancer in the lung | IPG716 | | |
| Stereotactic radiosurgery for trigeminal neuralgia | IPG715 | | |
| Colorectal cancer | QS20 | | |
| Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care | MTG65 | | |
| Glaucoma: diagnosis and management | NG81 | | |
| Sodium zirconium cyclosilicate for treating hyperkalaemia | TA599 | | |
| Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection | TA761 | | |
| Rehabilitation after traumatic injury | NG211 | | |
| Selpercatinib for previously treated RET fusion-positive advanced non-small-cell lung cancer | TA760 | | |
| Smart Peak Flow for monitoring asthma | MIB282 | | |
| Solriamfetol for treating excessive daytime sleepiness caused by narcolepsy | TA758 | | |
| Cabotegravir with rilpivirine for treating HIV-1 | TA757 | | |
| Prostate cancer | QS91 | | |
| Headaches in over 12s: diagnosis and management | CG150 | | |
| Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis | TA756 | | |
| Endo-SPONGE for treating low rectal anastomotic leak | MTG63 | | |
| Mogamulizumab for previously treated mycosis fungoides and Sézary syndrome | TA754 | | |
| Cenobamate for treating focal onset seizures in epilepsy | TA753 | | |
| Belimumab for treating active autoantibody-positive systemic lupus erythematosus | TA752 | | |
| Colorectal cancer | NG151 | | |
| Prostate cancer: diagnosis and management | NG131 | | |
| Endobronchial nerve ablation for chronic obstructive pulmonary disease | IPG714 | | |
| Transanal total mesorectal excision for rectal cancer | IPG713 | | |
| ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections | MTG62 | | |
| Urinary incontinence in women | QS77 | | |
| Pelvic floor dysfunction: prevention and non-surgical management | NG210 | | |
| Dupilumab for treating severe asthma with type 2 inflammation | TA751 | | |
| Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal) | TA750 | | |
| Brain tumours (primary) and brain metastases in over 16s | QS203 | | |
| FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome | MIB281 | | |
| Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal) | TA749 | | |
| Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders | TA748 | | |
| Synergo for non-muscle-invasive bladder cancer | MTG61 | | |
| Paige Prostate for prostate cancer | MIB280 | | |
| CerebAir for continuous EEG monitoring in intensive care | MIB279 | | |
| clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemia | MIB278 | | |
| Fever in under 5s: assessment and initial management | NG143 | | |
| Chronic kidney disease: assessment and management | NG203 | | |
| Coronary sinus narrowing device implantation for refractory angina | IPG712 | | |
| Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failure | IPG711 | | |
| Givosiran for treating acute hepatic porphyria | HST16 | | |
| Nintedanib for treating progressive fibrosing interstitial lung diseases | TA747 | | |
| Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancer | TA746 | | |
| Heart valve disease presenting in adults: investigation and management | NG208 | | |
| SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea | DG44 | | |
| Acute heart failure: diagnosis and management | CG187 | | |
| NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal) | TA745 | | |
| Upadacitinib for treating moderate rheumatoid arthritis | TA744 | | |
| Inducing labour | QS60 | | |
| Inducing labour | NG207 | | |
| Selpercatinib for treating advanced thyroid cancer with RET alterations | TA742 | | |
| 24/7 EEG SubQ for epilepsy | MIB277 | | |
| Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | NG206 | | |
| Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer | TA741 | | |
| Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancer | TA740 | | |
| Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitable | TA739 | | |
| Laparoscopic renal denervation for loin pain haematuria syndrome | IPG709 | | |
| Genicular artery embolisation for pain from knee osteoarthritis | IPG708 | | |
| Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access | IPG710 | | |
| Berotralstat for preventing recurrent attacks of hereditary angioedema | TA738 | | |
| Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer | TA737 | | |
| Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy | TA736 | | |
| Tofacitinib for treating juvenile idiopathic arthritis | TA735 | | |
| Looked-after children and young people | NG205 | | |
| Secukinumab for treating moderate to severe plaque psoriasis in children and young people | TA734 | | |
| Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia | TA733 | | |
| Baloxavir marboxil for treating acute uncomplicated influenza (terminated appraisal) | TA732 | | |
| DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiography | MTG60 | | |
| Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal) | TA730 | | |
| Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal) | TA731 | | |
| Sapropterin for treating hyperphenylalaninaemia in phenylketonuria | TA729 | | |
| Midostaurin for treating advanced systemic mastocytosis | TA728 | | |
| Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA727 | | |
| Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA726 | | |
| Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repair | IPG707 | | |
| Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis | IPG706 | | |
| Lateral elbow resurfacing for arthritis | IPG705 | | |
| Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy | TA725 | | |
| Carnation Ambulatory Monitor for ambulatory detection of cardiac arrythmias | MIB276 | | |
| OrganOx metra for liver transplant | MIB275 | | |
| Nivolumab with ipilimumab and chemotherapy for untreated metastatic non-small-cell lung cancer | TA724 | | |
| Workplace health: long-term sickness absence and capability to work | QS202 | | |
| End of life care for adults | QS13 | | |
| Bimekizumab for treating moderate to severe plaque psoriasis | TA723 | | |
| PLASMA system with button electrode for electrovaporisation of the prostate | MIB274 | | |
| Colli-Pee for first void urine collection | MIB273 | | |
| Pemigatinib for treating relapsed or refractory advanced cholangiocarcinoma with FGFR2 fusion or rearrangement | TA722 | | |
| Babies, children and young people's experience of healthcare | NG204 | | |
| Hysteroscopic mechanical tissue removal (hysteroscopic morcellation) for uterine fibroids | IPG704 | | |
| Laparoscopic removal of uterine fibroids with power morcellation | IPG703 | | |
| Magnetic resonance therapy for knee osteoarthritis | IPG702 | | |
| Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome | TA139 | | |
| Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s | NG202 | | |
| Venous thromboembolism in adults | QS201 | | |
| Antenatal care | NG201 | | |
| Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer | TA721 | | |
| Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma | TA720 | | |
| Melatonin for treating sleep disorders in adults who are blind | ES38 | | |
| Lung texture analysis for measuring interstitial lung diseases | MIB272 | | |
| Patient Status Engine for wireless monitoring of vital signs | MIB271 | | |
| MMprofiler for prognostic risk classification in multiple myeloma | MIB270 | | |
| Antimicrobial prescribing: delafloxacin for community-acquired pneumonia | ES37 | | |
| Bronchiolitis in children: diagnosis and management | NG9 | | |
| Immunoscore for predicting risk of colon cancer relapse | MIB269 | | |
| Nivolumab with ipilimumab for previously treated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency | TA716 | | |
| Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage | IPG701 | | |
| Clostridioides difficile infection: antimicrobial prescribing | NG199 | | |
| Secukinumab for treating non-radiographic axial spondyloarthritis | TA719 | | |
| Ixekizumab for treating axial spondyloarthritis | TA718 | | |
| Duvelisib for treating relapsed follicular lymphoma after 2 or more systemic therapies (terminated appraisal) | TA717 | | |
| ENDURALIFE powered CRT-D devices for treating heart failure | MTG33 | | |
| Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed | TA715 | | |
| Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal) | TA714 | | |
| trublood-prostate for triaging and diagnosing people with prostate cancer symptoms | MIB268 | | |
| HealthVCF for detecting vertebral compression fractures on CT scans | MIB267 | | |
| Nivolumab for advanced non-squamous non-small-cell lung cancer after chemotherapy | TA713 | | |
| Enzalutamide for treating hormone-sensitive metastatic prostate cancer | TA712 | | |
| Acumen IQ sensor for predicting hypotension risk | MIB266 | | |
| AI technologies for detecting diabetic retinopathy | MIB265 | | |
| Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation | TA355 | | |
| Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation | TA275 | | |
| Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation | TA256 | | |
| Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation | TA249 | | |
| Atrial fibrillation: diagnosis and management | NG196 | | |
| Plus Sutures for preventing surgical site infection | MTG59 | | |
| Ravulizumab for treating atypical haemolytic uraemic syndrome | TA710 | | |
| Pembrolizumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency | TA709 | | |
| Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis | TA708 | | |
| Percutaneous insertion of a closure device to repair a paravalvular leak around a replaced mitral or aortic valve | IPG700 | | |
| Laser lithotripsy for difficult-to-treat bile duct stones | IPG699 | | |
| Shared decision making | NG197 | | |
| Patient experience in adult NHS services: improving the experience of care for people using adult NHS services | CG138 | | |
| Nivolumab for previously treated unresectable advanced or recurrent oesophageal cancer | TA707 | | |
| SYNE-COV for predicting COVID-19 outcomes | MIB264 | | |
| Autism spectrum disorder in under 19s: support and management | CG170 | | |
| Autism spectrum disorder in adults: diagnosis and management | CG142 | | |
| Ozanimod for treating relapsing–remitting multiple sclerosis | TA706 | | |
| Atezolizumab monotherapy for untreated advanced non-small-cell lung cancer | TA705 | | |
| WoundExpress to manage lower leg wounds | MIB261 | | |
| Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies | TA704 | | |
| Ibrutinib with rituximab for untreated chronic lymphocytic leukaemia (terminated appraisal) | TA703 | | |
| Ibrutinib with obinutuzumab for untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (terminated appraisal) | TA702 | | |
| Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant | IPG695 | | |
| Electrohydraulic lithotripsy for difficult-to-treat bile duct stones | IPG698 | | |
| Transvaginal laser therapy for urogenital atrophy | IPG697 | | |
| Transvaginal laser therapy for stress urinary incontinence | IPG696 | | |
| Heavy menstrual bleeding: assessment and management | NG88 | | |
| Crisaborole for treating mild to moderate atopic dermatitis in people 2 years and older (terminated appraisal) | TA701 | | |
| Ofatumumab for treating relapsing multiple sclerosis | TA699 | | |
| Ravulizumab for treating paroxysmal nocturnal haemoglobinuria | TA698 | | |
| HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography | MTG32 | | |
| Parafricta Bootees and Undergarments to reduce skin breakdown in people with or at risk of pressure ulcers | MTG20 | | |
| Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban | TA697 | | |
| KODEX-EPD for cardiac imaging during ablation of arrhythmias | MIB260 | | |
| Permanent His-bundle pacemaker implantation for treating heart failure | IPG694 | | |
| UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia | MTG58 | | |
| Axonics sacral neuromodulation system for faecal incontinence | MIB259 | | |
| Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma | TA695 | | |
| Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia | TA694 | | |
| Pembrolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy | TA692 | | |
| Deep brain stimulation for chronic, severe, treatment-resistant obsessive-compulsive disorder in adults | IPG693 | | |
| Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma | IPG692 | | |
| Avelumab for untreated metastatic Merkel cell carcinoma | TA691 | | |
| Acalabrutinib for treating chronic lymphocytic leukaemia | TA689 | | |
| Avelumab for treating metastatic Merkel cell carcinoma | TA517 | | |
| microINR for anticoagulation therapy | MIB257 | | |
| Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver | IPG691 | | |
| Postnatal care | NG194 | | |
| Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain | NG193 | | |
| RenalSense Clarity RMS for acute kidney injury | MIB256 | | |
| Selective internal radiation therapies for treating hepatocellular carcinoma | TA688 | | |
| Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy | TA687 | | |
| Blinatumomab for previously treated Philadelphia-chromosome-positive acute lymphoblastic leukaemia (terminated appraisal) | TA686 | | |
| Anakinra for treating Still's disease | TA685 | | |
| Caesarean birth | QS32 | | |
| Danis stent for acute oesophageal variceal bleeding | MTG57 | | |
| Extracorporeal whole liver perfusion for acute liver failure | IPG690 | | |
| Transcervical ultrasound-guided radiofrequency ablation for symptomatic uterine fibroids | IPG689 | | |
| Sonata system for diagnostic imaging and treatment of symptomatic uterine fibroids | MIB255 | | |
| Asthma: diagnosis, monitoring and chronic asthma management | NG80 | | |
| Cannabis-based medicinal products | NG144 | | |
| Supporting adult carers | QS200 | | |
| Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease | TA684 | | |
| QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography | DG43 | | |
| Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer | TA683 | | |
| Erenumab for preventing migraine | TA682 | | |
| Alpha-Stim AID for anxiety disorders | MTG56 | | |
| Butterfly iQ+ for diagnostic ultrasound imaging | MIB254 | | |
| Baricitinib for treating moderate to severe atopic dermatitis | TA681 | | |
| Lenalidomide maintenance treatment after an autologous stem cell transplant for newly diagnosed multiple myeloma | TA680 | | |
| Cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis | IPG688 | | |
| Free-functioning gracilis transfer to restore upper limb function in brachial plexus injury | IPG687 | | |
| Secondary bacterial infection of eczema and other common skin conditions: antimicrobial prescribing | NG190 | | |
| Safeguarding adults in care homes | NG189 | | |
| Dapagliflozin for treating chronic heart failure with reduced ejection fraction | TA679 | | |
| Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) | TA678 | | |
| Brexucabtagene autoleucel for treating relapsed or refractory mantle cell lymphoma | TA677 | | |
| Filgotinib for treating moderate to severe rheumatoid arthritis | TA676 | | |
| Metreleptin for treating lipodystrophy | HST14 | | |
| Remsima (infliximab biosimilar) for subcutaneous injection for managing Crohn's disease and ulcerative colitis | ES35 | | |
| Vernakalant for the rapid conversion of recent onset atrial fibrillation to sinus rhythm (terminated appraisal) | TA675 | | |
| Pembrolizumab for untreated PD-L1-positive, locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (terminated appraisal) | TA674 | | |
| Niraparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy | TA673 | | |
| The STAK tool for preventing and treating knee stiffness | MIB252 | | |
| moorLDLS-BI for burn depth assessment | MIB251 | | |
| PROPEL sinus implants for maintaining sinus patency after surgery | MIB253 | | |
| Trabectedin for the treatment of advanced soft tissue sarcoma | TA185 | | |
| URO17 for detecting bladder cancer | MIB250 | | |
| Brolucizumab for treating wet age-related macular degeneration | TA672 | | |
| Mepolizumab for treating severe eosinophilic asthma | TA671 | | |
| Leukomed Sorbact for preventing surgical site infection | MTG55 | | |
| CytoSorb for reducing risk of bleeding during cardiac surgery | MIB249 | | |
| DOAC Dipstick for detecting direct oral anticoagulants | MIB248 | | |
| Brain tumours (primary) and brain metastases in over 16s | NG99 | | |
| Brigatinib for ALK-positive advanced non-small-cell lung cancer that has not been previously treated with an ALK inhibitor | TA670 | | |
| The VAC Veraflo Therapy system for acute infected or chronic wounds that are failing to heal | MTG54 | | |
| Minimally invasive radical hysterectomy for early stage cervical cancer | IPG686 | | |
| Self-expanding implant insertion into the intersphincteric space for faecal incontinence | IPG685 | | |
| Abortion care | QS199 | | |
| AcQMap for mapping the heart atria to target ablation treatment for arrhythmias | MIB246 | | |
| Accuro for guiding epidural or spinal anaesthesia | MIB245 | | |
| Natural Cycles for monitoring fertility | MIB244 | | |
| Suspected neurological conditions: recognition and referral | QS198 | | |
| Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer | TA668 | | |
| The PLASMA system for transurethral resection and haemostasis of the prostate | MTG53 | | |
| Artificial intelligence for analysing chest CT images | MIB243 | | |
| Artificial intelligence in mammography | MIB242 | | |
| Optilume for anterior urethral strictures | MIB241 | | |
| Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections | ES32 | | |
| Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura | TA667 | | |
| Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma | TA666 | | |
| Eating disorders: recognition and treatment | NG69 | | |
| Diabetes in pregnancy: management from preconception to the postnatal period | NG3 | | |
| Pancreatitis | NG104 | | |
| Cytosponge for detecting abnormal cells in the oesophagus | MIB240 | | |
| ReStore Soft Exo-Suit for gait rehabilitation | MIB239 | | |
| Low back pain and sciatica in over 16s: assessment and management | NG59 | | |
| Peripheral arterial disease: diagnosis and management | CG147 | | |
| Liraglutide for managing overweight and obesity | TA664 | | |
| Venetoclax with obinutuzumab for untreated chronic lymphocytic leukaemia | TA663 | | |
| Upadacitinib for treating severe rheumatoid arthritis | TA665 | | |
| Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain | MIB238 | | |
| Zio XT for detecting cardiac arrhythmias | MTG52 | | |
| Durvalumab in combination for untreated extensive-stage small-cell lung cancer (terminated appraisal) | TA662 | | |
| Pembrolizumab for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma | TA661 | | |
| Darolutamide with androgen deprivation therapy for treating hormone-relapsed non-metastatic prostate cancer | TA660 | | |
| QuickChange Incontinence Wrap for urinary incontinence in men | MIB237 | | |
| Galcanezumab for preventing migraine | TA659 | | |
| Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma | TA658 | | |
| Carfilzomib for previously treated multiple myeloma | TA657 | | |
| Siponimod for treating secondary progressive multiple sclerosis | TA656 | | |
| Guidance on the use of coronary artery stents | TA71 | | |
| Drug-eluting stents for the treatment of coronary artery disease | TA152 | | |
| Acute coronary syndromes in adults | QS68 | | |
| Acute coronary syndromes | NG185 | | |
| Swallowable gastric balloon capsule for weight loss | IPG684 | | |
| Magseed for locating impalpable breast cancer lesions | MIB236 | | |
| NPi-200 for pupillary light reflex in critical care patients | MIB235 | | |
| Human and animal bites: antimicrobial prescribing | NG184 | | |
| Dexcom G6 for real-time continuous glucose monitoring | MIB233 | | |
| Balloon cryoablation for squamous dysplasia of the oesophagus | IPG683 | | |
| Balloon cryoablation for Barrett's oesophagus | IPG682 | | |
| Pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis | IPG681 | | |
| Antimicrobial prescribing: imipenem with cilastatin and relebactam | ES30 | | |
| Testing strategies for Lynch syndrome in people with endometrial cancer | DG42 | | |
| Tegaderm CHG securement dressing for vascular access sites | MIB231 | | |
| Nivolumab for advanced squamous non-small-cell lung cancer after chemotherapy | TA655 | | |
| Volanesorsen for treating familial chylomicronaemia syndrome | HST13 | | |
| Heavy menstrual bleeding | QS47 | | |
| Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer | TA654 | | |
| Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer | TA653 | | |
| SEM Scanner 200 for preventing pressure ulcers | MTG51 | | |
| Rheumatoid arthritis in adults: management | NG100 | | |
| Behaviour change: digital and mobile health interventions | NG183 | | |
| Naldemedine for treating opioid-induced constipation | TA651 | | |
| Pembrolizumab with axitinib for untreated advanced renal cell carcinoma | TA650 | | |
| Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphoma | TA649 | | |
| Novii Wireless Patch System for maternal and fetal monitoring | MIB228 | | |
| Transcranial magnetic stimulation for auditory hallucinations | IPG680 | | |
| Insect bites and stings: antimicrobial prescribing | NG182 | | |
| t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes | MIB227 | | |
| Neuropathic pain in adults: pharmacological management in non-specialist settings | CG173 | | |
| Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal) | TA648 | | |
| Axonics sacral neuromodulation system for treating refractory overactive bladder | MTG50 | | |
| Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal) | TA647 | | |
| Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal) | TA646 | | |
| Avelumab with axitinib for untreated advanced renal cell carcinoma | TA645 | | |
| Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | DG41 | | |
| Helge for detecting haemolysis | MIB225 | | |
| Faltering growth | QS197 | | |
| Community pharmacies: promoting health and wellbeing | QS196 | | |
| FebriDx for C-reactive protein and myxovirus resistance protein A testing | MIB224 | | |
| High-sensitivity troponin tests for the early rule out of NSTEMI | DG40 | | |
| Anaphylaxis: assessment and referral after emergency treatment | CG134 | | |
| Rehabilitation for adults with complex psychosis | NG181 | | |
| Perioperative care in adults | NG180 | | |
| Surgical site infections: prevention and treatment | NG125 | | |
| Entrectinib for treating NTRK fusion-positive solid tumours | TA644 | | |
| Entrectinib for treating ROS1-positive advanced non-small-cell lung cancer | TA643 | | |
| Gilteritinib for treating relapsed or refractory acute myeloid leukaemia | TA642 | | |
| Brentuximab vedotin in combination for untreated systemic anaplastic large cell lymphoma | TA641 | | |
| Implanted vagus nerve stimulation for treatment-resistant depression | IPG679 | | |
| Deep brain stimulation for refractory epilepsy in adults | IPG678 | | |
| Decision making and mental capacity | QS194 | | |
| Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome | MIB223 | | |
| pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms | MIB222 | | |
| Healthy.io test for home testing of urine albumin to creatinine ratio | MIB221 | | |
| Treosulfan with fludarabine for malignant disease before allogeneic stem cell transplant | TA640 | | |
| Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease | IPG677 | | |
| Transcranial magnetic stimulation for obsessive-compulsive disorder | IPG676 | | |
| Renal and ureteric stones | QS195 | | |
| Artificial iris insertion for congenital aniridia | IPG675 | | |
| Artificial iris insertion for acquired aniridia | IPG674 | | |
| Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis | ES29 | | |
| Specialist neonatal respiratory care for babies born preterm | QS193 | | |
| CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic | MIB219 | | |
| Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer | TA639 | | |
| Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer | TA638 | | |
| Ranibizumab for treating diabetic retinopathy (terminated appraisal) | TA637 | | |
| Eculizumab for treating refractory myasthenia gravis (terminated appraisal) | TA636 | | |
| Ramucirumab with erlotinib for untreated EGFR-positive metastatic non-small-cell lung cancer (terminated appraisal) | TA635 | | |
| Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma (terminated appraisal) | TA634 | | |
| Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure | TA626 | | |
| Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia | MTG49 | | |
| Intravascular lithotripsy for calcified coronary arteries during percutaneous coronary intervention | IPG673 | | |
| MolecuLight i:X for wound imaging | MIB212 | | |
| Actim Pancreatitis for diagnosing acute pancreatitis | MIB218 | | |
| Ustekinumab for treating moderately to severely active ulcerative colitis | TA633 | | |
| Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) | DG39 | | |
| Generalised anxiety disorder and panic disorder in adults: management | CG113 | | |
| Intravenous fluid therapy in children and young people in hospital | NG29 | | |
| Archimedes for biopsy of suspected lung cancer | MIB211 | | |
| Trastuzumab emtansine for adjuvant treatment of HER2-positive early breast cancer | TA632 | | |
| Joint replacement (primary): hip, knee and shoulder | NG157 | | |
| Larotrectinib for treating NTRK fusion-positive solid tumours | TA630 | | |
| Cytokine adsorption devices for treating respiratory failure in people with COVID-19 | MIB217 | | |
| Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab | TA629 | | |
| Lorlatinib for previously treated ALK-positive advanced non-small-cell lung cancer | TA628 | | |
| PneuX to prevent ventilator-associated pneumonia | MTG48 | | |
| Lifelight First for monitoring vital signs | MIB213 | | |
| Lenalidomide with rituximab for previously treated follicular lymphoma | TA627 | | |
| Abdominal aortic aneurysm: diagnosis and management | NG156 | | |
| TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation | MIB210 | | |
| NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wounds | MIB208 | | |
| Artificial intelligence for analysing CT brain scans | MIB207 | | |
| Tinnitus: assessment and management | NG155 | | |
| Cor-Knot for tying suture knots in valve surgery | MIB206 | | |
| Recombinant human parathyroid hormone for treating hypoparathyroidism (terminated appraisal) | TA625 | | |
| Selective internal radiation therapy for unresectable colorectal metastases in the liver | IPG672 | | |
| MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy | IPG671 | | |
| Cyanoacrylate glue occlusion for varicose veins | IPG670 | | |
| Bilateral cervicosacropexy (CESA) or vaginosacropexy (VASA) using mesh for pelvic organ prolapse | IPG669 | | |
| Intrapartum care: existing medical conditions and obstetric complications | QS192 | | |
| Neonatal parenteral nutrition | NG154 | | |
| Impetigo: antimicrobial prescribing | NG153 | | |
| Peginterferon beta-1a for treating relapsing–remitting multiple sclerosis | TA624 | | |
| SepsiTest assay for rapidly identifying bloodstream bacteria and fungi | DG20 | | |
| National Early Warning Score systems that alert to deteriorating adult patients in hospital | MIB205 | | |
| Patiromer for treating hyperkalaemia | TA623 | | |
| Sotagliflozin with insulin for treating type 1 diabetes | TA622 | | |
| Leg ulcer infection: antimicrobial prescribing | NG152 | | |
| Episcissors-60 for mediolateral episiotomy | MTG47 | | |
| Antenatal and postnatal mental health: clinical management and service guidance | CG192 | | |
| Cerebral palsy in adults | QS191 | | |
| Open prenatal repair for open neural tube defects in the fetus | IPG668 | | |
| Fetoscopic prenatal repair for open neural tube defects in the fetus | IPG667 | | |
| Supporting adult carers | NG150 | | |
| Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues | IPG666 | | |
| Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C | MTG27 | | |
| Atezolizumab with carboplatin and nab-paclitaxel for untreated advanced non-squamous non-small-cell lung cancer (terminated appraisal) | TA618 | | |
| Rheumatoid arthritis in over 16s | QS33 | | |
| Flu vaccination: increasing uptake | QS190 | | |
| Lusutrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure | TA617 | | |
| Indoor air quality at home | NG149 | | |
| Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome | TA615 | | |
| Cannabidiol with clobazam for treating seizures associated with Dravet syndrome | TA614 | | |
| Balloon dilation for chronic eustachian tube dysfunction | IPG665 | | |
| Antimicrobial prescribing: ceftolozane with tazobactam for treating hospital-acquired pneumonia, including ventilator-associated pneumonia | ES22 | | |
| PulmoVista 500 for monitoring ventilation in critical care | MIB203 | | |
| LQD Spray for treating acute and chronic wounds | MIB202 | | |
| Lung cancer in adults | QS17 | | |
| eXroid for internal haemorrhoids | MIB201 | | |
| PIUR tUS for abdominal aortic aneurysm surveillance and endovascular aneurysm repair endoleak detection | MIB200 | | |
| Menopause: diagnosis and management | NG23 | | |
| gammaCore for cluster headache | MTG46 | | |
| Optowire for measuring fractional flow reserve | MIB199 | | |
| Diverticular disease: diagnosis and management | NG147 | | |
| Irreversible electroporation for primary liver cancer | IPG664 | | |
| Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 | HST12 | | |
| AmnioSense for unexplained vaginal wetness in pregnancy | MIB198 | | |
| Neratinib for extended adjuvant treatment of hormone receptor-positive, HER2-positive early stage breast cancer after adjuvant trastuzumab | TA612 | | |
| Workplace health: long-term sickness absence and capability to work | NG146 | | |
| Antimicrobial prescribing: meropenem with vaborbactam | ES21 | | |
| Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer | TA611 | | |
| Pentosan polysulfate sodium for treating bladder pain syndrome | TA610 | | |
| Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast | DG37 | | |
| Ramucirumab for treating unresectable hepatocellular carcinoma after sorafenib (terminated appraisal) | TA609 | | |
| Ibrutinib with rituximab for treating Waldenstrom's macroglobulinaemia (terminated appraisal) | TA608 | | |
| Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management | CG184 | | |
| Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease | TA607 | | |
| Lanadelumab for preventing recurrent attacks of hereditary angioedema | TA606 | | |
| End of life care for adults: service delivery | NG142 | | |
| Midcarpal hemiarthroplasty for wrist arthritis | IPG663 | | |
| Diabetic foot problems: prevention and management | NG19 | | |
| MR-proADM test for use with clinical deterioration scores in cases of suspected infection | MIB195 | | |
| superDimension Navigation System to help diagnostic sampling of peripheral lung lesions | MIB194 | | |
| Xeomin (botulinum neurotoxin type A) for treating chronic sialorrhoea | TA605 | | |
| Gastro-oesophageal reflux disease in children and young people: diagnosis and management | NG1 | | |
| Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations | HST11 | | |
| EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing | MTG12 | | |
| Familial hypercholesterolaemia: identification and management | CG71 | | |
| Idelalisib for treating refractory follicular lymphoma | TA604 | | |
| Cellulitis and erysipelas: antimicrobial prescribing | NG141 | | |
| Lenalidomide with bortezomib and dexamethasone for untreated multiple myeloma (terminated appraisal) | TA603 | | |
| Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA602 | | |
| Abortion care | NG140 | | |
| Bioprosthetic plug insertion for anal fistula | IPG662 | | |
| High-intensity focused ultrasound for glaucoma | IPG661 | | |
| Tegaderm CHG securement dressing for vascular access sites in critically ill adults | MTG25 | | |
| Pneumonia (hospital-acquired): antimicrobial prescribing | NG139 | | |
| Pneumonia (community-acquired): antimicrobial prescribing | NG138 | | |
| Attention deficit hyperactivity disorder: diagnosis and management | NG87 | | |
| Implant insertion for prominent ears | IPG660 | | |
| Suicide prevention | QS189 | | |
| InterDry for intertrigo | MIB192 | | |
| SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea | MIB190 | | |
| Multiple pregnancy: twin and triplet pregnancies | QS46 | | |
| Benralizumab for treating severe eosinophilic asthma | TA565 | | |
| Risankizumab for treating moderate to severe plaque psoriasis | TA596 | | |
| Coexisting severe mental illness and substance misuse | QS188 | | |
| Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer | TA595 | | |
| Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal) | TA594 | | |
| Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer | IPG659 | | |
| Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysms | IPG658 | | |
| Patisiran for treating hereditary transthyretin amyloidosis | HST10 | | |
| Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | NG89 | | |
| Alcohol interventions in secondary and further education | NG135 | | |
| PICO negative pressure wound dressings for closed surgical incisions | MTG43 | | |
| Preterm labour and birth | QS135 | | |
| Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis | TA590 | | |
| Letermovir for preventing cytomegalovirus disease after a stem cell transplant | TA591 | | |
| Patient experience in adult NHS services | QS15 | | |
| Service user experience in adult mental health services | QS14 | | |
| Chronic obstructive pulmonary disease in over 16s: diagnosis and management | NG115 | | |
| End of life care for infants, children and young people with life-limiting conditions: planning and management | NG61 | | |
| Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activity | TA589 | | |
| Nusinersen for treating spinal muscular atrophy | TA588 | | |
| Learning disability: care and support of people growing older | QS187 | | |
| Learning disability: behaviour that challenges | QS101 | | |
| Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroids | IPG657 | | |
| Transurethral laser ablation for recurrent non-muscle-invasive bladder cancer | IPG656 | | |
| Hypertension in pregnancy | QS35 | | |
| Motor neurone disease: assessment and management | NG42 | | |
| HemaClear for bloodless surgical field during limb surgery | MIB187 | | |
| Lyme disease | QS186 | | |
| Hearing loss in adults | QS185 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis | DG36 | | |
| Bisphosphonates for treating osteoporosis | TA464 | | |
| Long-acting reversible contraception | CG30 | | |
| Dementia | QS184 | | |
| The OPTIMIZER smart system for managing heart failure | MIB186 | | |
| Lenalidomide plus dexamethasone for previously untreated multiple myeloma | TA587 | | |
| Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib | TA586 | | |
| Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality | TA322 | | |
| Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies | TA171 | | |
| Cardiac contractility modulation device implantation for heart failure | IPG655 | | |
| Reinforcement of a permanent stoma with a synthetic or biological mesh to prevent a parastomal hernia | IPG654 | | |
| Valve-in-valve TAVI for aortic bioprosthetic valve dysfunction | IPG653 | | |
| Depression in children and young people: identification and management | NG134 | | |
| Urinary incontinence and pelvic organ prolapse in women: management | NG123 | | |
| Ambu aScope4 Broncho for use in unexpected difficult airways | MTG14 | | |
| Ocrelizumab for treating primary progressive multiple sclerosis | TA585 | | |
| Percutaneous mechanical thrombectomy for acute deep vein thrombosis of the leg | IPG651 | | |
| Percutaneous insertion of a cerebral protection device to prevent cerebral embolism during TAVI | IPG650 | | |
| Bronchoscopic thermal vapour ablation for upper-lobe emphysema | IPG652 | | |
| Endocuff Vision for assisting visualisation during colonoscopy | MTG45 | | |
| Physical activity: encouraging activity in the community | QS183 | | |
| Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer | TA584 | | |
| Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes | TA583 | | |
| The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters | MTG24 | | |
| Percutaneous mitral valve leaflet repair for mitral regurgitation | IPG649 | | |
| Collagen paste for closing an anal fistula | IPG648 | | |
| Therapeutic hypothermia for acute ischaemic stroke | IPG647 | | |
| Hyperparathyroidism (primary): diagnosis, assessment and initial management | NG132 | | |
| Inotersen for treating hereditary transthyretin amyloidosis | HST9 | | |
| Enzalutamide for hormone-relapsed non-metastatic prostate cancer | TA580 | | |
| Curos for preventing infections when using needleless connectors | MTG44 | | |
| DuraGraft for preserving vascular grafts | MIB184 | | |
| Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care | DG35 | | |
| Ulcerative colitis: management | NG130 | | |
| Crohn's disease: management | NG129 | | |
| Intrapartum care for women with existing medical conditions or obstetric complications and their babies | NG121 | | |
| Brentuximab vedotin for treating CD30-positive cutaneous T-cell lymphoma | TA577 | | |
| Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) | TA576 | | |
| Tildrakizumab for treating moderate to severe plaque psoriasis | TA575 | | |
| Certolizumab pegol for treating moderate to severe plaque psoriasis | TA574 | | |
| Endoscopic ablation for a pilonidal sinus | IPG646 | | |
| Endoscopic ablation for an anal fistula | IPG645 | | |
| ADXBLADDER for detecting bladder cancer | MIB180 | | |
| Specialist neonatal respiratory care for babies born preterm | NG124 | | |
| Narrow band imaging for Barrett's oesophagus | MIB179 | | |
| Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes | TA572 | | |
| The Debrisoft monofilament debridement pad for use in acute or chronic wounds | MTG17 | | |
| Brigatinib for treating ALK-positive advanced non-small-cell lung cancer after crizotinib | TA571 | | |
| Pembrolizumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy (terminated appraisal) | TA570 | | |
| Pertuzumab for adjuvant treatment of HER2-positive early stage breast cancer | TA569 | | |
| Kendall DL for ECG monitoring in people having cardiac surgery | MIB177 | | |
| Abatacept for treating psoriatic arthritis after DMARDs (terminated appraisal) | TA568 | | |
| Radially emitting laser fibre treatment of an anal fistula | IPG644 | | |
| Cochlear implants for children and adults with severe to profound deafness | TA566 | | |
| IQoro for hiatus hernia | MIB176 | | |
| IQoro for stroke-related dysphagia | MIB175 | | |
| CADScor system for ruling out coronary artery disease in people with symptoms of stable coronary artery disease | MIB174 | | |
| People's experience using adult social care services | QS182 | | |
| Air pollution: outdoor air quality and health | QS181 | | |
| Prevena incision management system for closed surgical incisions | MIB173 | | |
| Abemaciclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | TA563 | | |
| Encorafenib with binimetinib for unresectable or metastatic BRAF V600 mutation-positive melanoma | TA562 | | |
| Venetoclax with rituximab for previously treated chronic lymphocytic leukaemia | TA561 | | |
| High-intensity focused ultrasound for symptomatic benign thyroid nodules | IPG643 | | |
| Bevacizumab with carboplatin, gemcitabine and paclitaxel for treating the first recurrence of platinum-sensitive advanced ovarian cancer (terminated appraisal) | TA560 | | |
| Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal | IPG642 | | |
| Opioid dependence: buprenorphine prolonged-release injection (Buvidal) | ES19 | | |
| Serious eye disorders | QS180 | | |
| Child abuse and neglect | QS179 | | |
| Axumin for functional imaging of prostate cancer recurrence | MIB172 | | |
| Cough (acute): antimicrobial prescribing | NG120 | | |
| Sexual health | QS178 | | |
| StoneChecker for kidney stone evaluation | MIB171 | | |
| Percutaneous venoplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis | IPG640 | | |
| Laparoscopic cerclage for cervical incompetence to prevent late miscarriage or preterm birth | IPG639 | | |
| Electrically stimulated intravesical chemotherapy for non-muscle-invasive bladder cancer | IPG638 | | |
| Path Finder for freezing of gait in people with Parkinson's disease | MIB170 | | |
| Senza spinal cord stimulation system for delivering HF10 therapy to treat chronic neuropathic pain | MTG41 | | |
| Platelet-rich plasma injections for knee osteoarthritis | IPG637 | | |
| RT300 for spinal cord injury rehabilitation | MIB169 | | |
| LiMAx system for assessing the functional capacity of the liver | MIB168 | | |
| Ex-situ machine perfusion for extracorporeal preservation of livers for transplantation | IPG636 | | |
| Cerebral palsy in adults | NG119 | | |
| Mepilex Border Heel and Sacrum dressings for preventing pressure ulcers | MTG40 | | |
| Darvadstrocel for treating complex perianal fistulas in Crohn's disease | TA556 | | |
| Regorafenib for previously treated advanced hepatocellular carcinoma | TA555 | | |
| Pipeline Flex embolisation device with Shield Technology for the treatment of complex intracranial aneurysms | MTG10 | | |
| Renal and ureteric stones: assessment and management | NG118 | | |
| Pancreatic cancer | QS177 | | |
| Liposomal cytarabine–daunorubicin for untreated acute myeloid leukaemia | TA552 | | |
| Lenvatinib for untreated advanced hepatocellular carcinoma | TA551 | | |
| Video laryngoscopes to help intubation in people with difficult airways | MIB167 | | |
| Bronchial thermoplasty for severe asthma | IPG635 | | |
| Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults | IPG634 | | |
| Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing | NG117 | | |
| Galaxy UNYCO for temporary stabilisation of lower limb fractures | MIB166 | | |
| Oesophago-gastric cancer | QS176 | | |
| Vandetanib for treating medullary thyroid cancer | TA550 | | |
| Decitabine for untreated acute myeloid leukaemia (terminated appraisal) | TA548 | | |
| Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) | TA549 | | |
| Post-traumatic stress disorder | NG116 | | |
| Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing | NG114 | | |
| Tofacitinib for moderately to severely active ulcerative colitis | TA547 | | |
| Percutaneous insertion of a temporary heart pump for left ventricular haemodynamic support in high-risk percutaneous coronary interventions | IPG633 | | |
| Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain | IPG632 | | |
| Urinary tract infection (catheter-associated): antimicrobial prescribing | NG113 | | |
| Padeliporfin for untreated localised prostate cancer | TA546 | | |
| Gemtuzumab ozogamicin for untreated acute myeloid leukaemia | TA545 | | |
| Subcutaneous automated low-flow pump implantation for refractory ascites caused by cirrhosis | IPG631 | | |
| Urinary tract infection (recurrent): antimicrobial prescribing | NG112 | | |
| Pyelonephritis (acute): antimicrobial prescribing | NG111 | | |
| Prostatitis (acute): antimicrobial prescribing | NG110 | | |
| Urinary tract infection (lower): antimicrobial prescribing | NG109 | | |
| Selective internal radiation therapy for unresectable primary intrahepatic cholangiocarcinoma | IPG630 | | |
| Eltrombopag for treating chronic immune thrombocytopenia | TA293 | | |
| Romiplostim for the treatment of chronic immune thrombocytopenia | TA221 | | |
| Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children | MIB163 | | |
| Myeloma: diagnosis and management | NG35 | | |
| Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma | TA544 | | |
| Lyme disease | NG95 | | |
| Burosumab for treating X-linked hypophosphataemia in children and young people | HST8 | | |
| Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs | TA543 | | |
| Cabozantinib for untreated advanced renal cell carcinoma | TA542 | | |
| Renal replacement therapy services for adults | QS72 | | |
| Decision-making and mental capacity | NG108 | | |
| Renal replacement therapy and conservative management | NG107 | | |
| E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta | MTG16 | | |
| myAIRVO2 for the treatment of chronic obstructive pulmonary disease | MIB161 | | |
| OxyMask for delivering oxygen therapy | MIB160 | | |
| Eating disorders | QS175 | | |
| Asthma | QS25 | | |
| Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia | TA541 | | |
| Intravesical microwave hyperthermia and chemotherapy for non-muscle-invasive bladder cancer | IPG628 | | |
| The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs | MIB159 | | |
| Chronic heart failure in adults: diagnosis and management | NG106 | | |
| Preventing suicide in community and custodial settings | NG105 | | |
| Emergency and acute medical care in over 16s | QS174 | | |
| Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours | TA539 | | |
| Superior rectal artery embolisation for haemorrhoids | IPG627 | | |
| Leadless cardiac pacemaker implantation for bradyarrhythmias | IPG626 | | |
| AlignRT in breast cancer radiotherapy | MIB157 | | |
| Neon EEG electrode for EEG monitoring in newborns | MIB155 | | |
| Dinutuximab beta for treating neuroblastoma | TA538 | | |
| Flu vaccination: increasing uptake | NG103 | | |
| Sutureless aortic valve replacement for aortic stenosis | IPG624 | | |
| Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia | IPG625 | | |
| Intermediate care including reablement | QS173 | | |
| Ixekizumab for treating active psoriatic arthritis after inadequate response to DMARDs | TA537 | | |
| Alectinib for untreated ALK-positive advanced non-small-cell lung cancer | TA536 | | |
| Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine | TA535 | | |
| Endometriosis | QS172 | | |
| Community pharmacies: promoting health and wellbeing | NG102 | | |
| Dupilumab for treating moderate to severe atopic dermatitis | TA534 | | |
| Low-intensity pulsed ultrasound to promote healing of delayed-union and non-union fractures | IPG623 | | |
| Low-intensity pulsed ultrasound to promote healing of fresh fractures at high risk of non-healing | IPG622 | | |
| Low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing | IPG621 | | |
| Mechanical thrombectomy devices for acute ischaemic stroke | MIB153 | | |
| Remote ECG interpretation consultancy services for cardiovascular disease | MIB152 | | |
| Ocrelizumab for treating relapsing–remitting multiple sclerosis | TA533 | | |
| Transaxial interbody lumbosacral fusion for severe chronic low back pain | IPG620 | | |
| Superior capsular augmentation for massive rotator cuff tears | IPG619 | | |
| Medicines management for people receiving social care in the community | QS171 | | |
| Pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer | TA531 | | |
| Airglove air warming system for venous access | MIB151 | | |
| Nivolumab for treating locally advanced unresectable or metastatic urothelial cancer after platinum-containing chemotherapy | TA530 | | |
| Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer | TA529 | | |
| Biomarker tests to help diagnose preterm labour in women with intact membranes | DG33 | | |
| Spondyloarthritis | QS170 | | |
| Beta interferons and glatiramer acetate for treating multiple sclerosis | TA527 | | |
| Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease | TA217 | | |
| Dementia: assessment, management and support for people living with dementia and their carers | NG97 | | |
| Laparoscopic ventral mesh rectopexy for internal rectal prolapse | IPG618 | | |
| Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor | IPG617 | | |
| ORA G3 to measure corneal hysteresis | MIB150 | | |
| Arsenic trioxide for treating acute promyelocytic leukaemia | TA526 | | |
| Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy | TA525 | | |
| Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma | TA524 | | |
| Midostaurin for untreated acute myeloid leukaemia | TA523 | | |
| Guselkumab for treating moderate to severe plaque psoriasis | TA521 | | |
| Intranasal phototherapy for allergic rhinitis | IPG616 | | |
| Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over | NG36 | | |
| VIDAvision for lung volume analysis in emphysema | MIB148 | | |
| Low-level laser therapy for preventing or treating oral mucositis caused by radiotherapy or chemotherapy | IPG615 | | |
| Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cancer | IPG614 | | |
| Developmental follow-up of children and young people born preterm | QS169 | | |
| Cystic fibrosis | QS168 | | |
| Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy | TA520 | | |
| AlignRT for intracranial stereotactic radiosurgery | MIB147 | | |
| Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups | QS167 | | |
| Percutaneous balloon valvuloplasty for fetal critical aortic stenosis | IPG613 | | |
| Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma | IPG612 | | |
| Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia | IPG611 | | |
| Robot-assisted kidney transplant | IPG609 | | |
| Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I | DG32 | | |
| Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema | MIB144 | | |
| Nerve transfer to partially restore upper limb function in tetraplegia | IPG610 | | |
| Tocilizumab for treating giant cell arteritis | TA518 | | |
| ColonFlag for identifying people at risk of colorectal cancer | MIB142 | | |
| Care and support of people growing older with learning disabilities | NG96 | | |
| Trauma | QS166 | | |
| Drug misuse prevention | QS165 | | |
| Cabozantinib for treating medullary thyroid cancer | TA516 | | |
| Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen | TA515 | | |
| Emergency and acute medical care in over 16s: service delivery and organisation | NG94 | | |
| Learning disabilities and behaviour that challenges: service design and delivery | NG93 | | |
| Physical activity and the environment | NG90 | | |
| Tivozanib for treating advanced renal cell carcinoma | TA512 | | |
| Brodalumab for treating moderate to severe plaque psoriasis | TA511 | | |
| Obinutuzumab for untreated advanced follicular lymphoma | TA513 | | |
| Attention deficit hyperactivity disorder | QS39 | | |
| Laparoscopic mesh pectopexy for apical prolapse of the uterus or vagina | IPG608 | | |
| Mosaicplasty for symptomatic articular cartilage defects of the knee | IPG607 | | |
| Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer | TA509 | | |
| Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee | TA508 | | |
| Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease | IPG606 | | |
| Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C | TA507 | | |
| People's experience in adult social care services: improving the experience of care and support for people using adult social care services | NG86 | | |
| Coban 2 for venous leg ulcers | MIB140 | | |
| Aortic valve reconstruction with processed bovine pericardium | IPG604 | | |
| Parkinson's disease | QS164 | | |
| Mental health of adults in contact with the criminal justice system | QS163 | | |
| Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women | TA161 | | |
| Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women | TA160 | | |
| Atrial fibrillation | QS93 | | |
| Pancreatic cancer in adults: diagnosis and management | NG85 | | |
| Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency | HST7 | | |
| Pirfenidone for treating idiopathic pulmonary fibrosis | TA504 | | |
| Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer | TA503 | | |
| Ibrutinib for treating relapsed or refractory mantle cell lymphoma | TA502 | | |
| Intrabeam radiotherapy system for adjuvant treatment of early breast cancer | TA501 | | |
| EpiFix for chronic wounds | MIB139 | | |
| Sore throat (acute): antimicrobial prescribing | NG84 | | |
| Minimally invasive percutaneous nephrolitholapaxy medium (MIP-M) for removing kidney stones | MIB138 | | |
| Ceritinib for untreated ALK-positive non-small-cell lung cancer | TA500 | | |
| Glecaprevir–pibrentasvir for treating chronic hepatitis C | TA499 | | |
| Lenvatinib with everolimus for previously treated advanced renal cell carcinoma | TA498 | | |
| Age-related macular degeneration | NG82 | | |
| Plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer | MIB137 | | |
| MammaTyper in vitro diagnostic test for determining breast cancer subtypes | MIB135 | | |
| TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum | MIB134 | | |
| Golimumab for treating non-radiographic axial spondyloarthritis | TA497 | | |
| Next-generation sequencing panel for solid tumour cancers in children | MIB133 | | |
| Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | TA496 | | |
| Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | TA495 | | |
| Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death | IPG603 | | |
| Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure | IPG602 | | |
| Transcutaneous microwave ablation for severe primary axillary hyperhidrosis | IPG601 | | |
| Endobronchial valve insertion to reduce lung volume in emphysema | IPG600 | | |
| Autism spectrum disorder in under 19s: recognition, referral and diagnosis | CG128 | | |
| Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) | DG14 | | |
| Transvaginal mesh repair of anterior or posterior vaginal wall prolapse | IPG599 | | |
| Naltrexone–bupropion for managing overweight and obesity | TA494 | | |
| Suspected cancer | QS124 | | |
| Point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease | MIB132 | | |
| Vismodegib for treating basal cell carcinoma | TA489 | | |
| Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoea | IPG598 | | |
| Processed nerve allografts to repair peripheral nerve discontinuities | IPG597 | | |
| Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane | TA458 | | |
| Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours | TA488 | | |
| Tests in secondary care to identify people at high risk of ovarian cancer | DG31 | | |
| Extracranial to intracranial bypass for intracranial atherosclerosis | IPG596 | | |
| Total distal radioulnar joint replacement for symptomatic joint instability or arthritis | IPG595 | | |
| HTG EdgeSeq ALKPlus Assay EU for ALK status testing in non-small-cell lung cancer | MIB128 | | |
| Familial hypercholesterolaemia | QS41 | | |
| Aflibercept for treating choroidal neovascularisation | TA486 | | |
| Sarilumab for moderate to severe rheumatoid arthritis | TA485 | | |
| Radiation dose monitoring software for medical imaging with ionising radiation | MIB127 | | |
| Sinusitis (acute): antimicrobial prescribing | NG79 | | |
| Cataracts in adults: management | NG77 | | |
| Cystic fibrosis: diagnosis and management | NG78 | | |
| Hepatitis B (chronic): diagnosis and management | CG165 | | |
| PleuraFlow Active Clearance Technology for maintaining chest tube patency | MIB125 | | |
| Immunosuppressive therapy for kidney transplant in children and young people | TA482 | | |
| Immunosuppressive therapy for kidney transplant in adults | TA481 | | |
| Tofacitinib for moderate to severe rheumatoid arthritis | TA480 | | |
| Cerebral palsy in children and young people | QS162 | | |
| Child abuse and neglect | NG76 | | |
| Child maltreatment: when to suspect maltreatment in under 18s | CG89 | | |
| Reslizumab for treating severe eosinophilic asthma | TA479 | | |
| Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma | TA478 | | |
| Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee | TA477 | | |
| Memokath-028, 044 and 045 stents for urethral obstruction | MIB123 | | |
| Thora-3Di for assessing asthma in children | MIB122 | | |
| FreeStyle Libre for glucose monitoring | MIB110 | | |
| Faltering growth: recognition and management of faltering growth in children | NG75 | | |
| Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease | IPG593 | | |
| Cetuximab and panitumumab for previously untreated metastatic colorectal cancer | TA439 | | |
| Intermediate care including reablement | NG74 | | |
| Caris Molecular Intelligence for guiding cancer treatment | MIB120 | | |
| Type 2 diabetes: prevention in people at high risk | PH38 | | |
| Aptiva for painful diabetic neuropathy | MIB119 | | |
| High-intensity focused ultrasound for symptomatic breast fibroadenoma | IPG592 | | |
| Ab externo canaloplasty for primary open-angle glaucoma | IPG591 | | |
| Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy | TA428 | | |
| Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab | TA357 | | |
| Pembrolizumab for advanced melanoma not previously treated with ipilimumab | TA366 | | |
| Transition between inpatient mental health settings and community or care home settings | QS159 | | |
| End of life care for infants, children and young people | QS160 | | |
| Rehabilitation after critical illness in adults | QS158 | | |
| HIV testing: encouraging uptake | QS157 | | |
| Physical health of people in prisons | QS156 | | |
| Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer | TA476 | | |
| Dimethyl fumarate for treating moderate to severe plaque psoriasis | TA475 | | |
| Sorafenib for treating advanced hepatocellular carcinoma | TA474 | | |
| Fertility problems: assessment and treatment | CG156 | | |
| Psoriasis: assessment and management | CG153 | | |
| Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck | TA473 | | |
| Fungitell for antifungal treatment stratification | MIB118 | | |
| Vitamin D: supplement use in specific population groups | PH56 | | |
| Idelalisib with ofatumumab for treating chronic lymphocytic leukaemia (terminated appraisal) | TA469 | | |
| Methylnaltrexone bromide for treating opioid-induced constipation (terminated appraisal) | TA468 | | |
| Radiofrequency treatment for haemorrhoids | IPG589 | | |
| Holoclar for treating limbal stem cell deficiency after eye burns | TA467 | | |
| Advanced breast cancer: diagnosis and treatment | CG81 | | |
| Pemetrexed for the maintenance treatment of non-small-cell lung cancer | TA190 | | |
| Baricitinib for moderate to severe rheumatoid arthritis | TA466 | | |
| Cabozantinib for previously treated advanced renal cell carcinoma | TA463 | | |
| Developmental follow-up of children and young people born preterm | NG72 | | |
| Biopatch for venous or arterial catheter sites | MIB117 | | |
| moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment | MTG2 | | |
| Urethrotech UCD for difficult or failed catheterisation | MIB116 | | |
| Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | CG32 | | |
| VEST external stent for coronary artery bypass grafts | MIB115 | | |
| Chronic kidney disease in adults | QS5 | | |
| Low back pain and sciatica in over 16s | QS155 | | |
| Nivolumab for treating relapsed or refractory classical Hodgkin lymphoma | TA462 | | |
| Roflumilast for treating chronic obstructive pulmonary disease | TA461 | | |
| Adalimumab and dexamethasone for treating non-infectious uveitis | TA460 | | |
| Transcatheter aortic valve implantation for aortic stenosis | IPG586 | | |
| Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry | MIB113 | | |
| Parkinson's disease in adults | NG71 | | |
| Arctic Sun 5000 for therapeutic hypothermia after cardiac arrest | MIB112 | | |
| Constipation in children and young people: diagnosis and management | CG99 | | |
| Ustekinumab for moderately to severely active Crohn's disease after previous treatment | TA456 | | |
| Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people | TA455 | | |
| Somatom Definition Edge CT scanner for imaging coronary artery disease in adults in whom imaging is difficult | MIB54 | | |
| Aquilion PRIME CT scanner for imaging coronary artery disease in adults in whom imaging is difficult | MIB53 | | |
| New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | DG3 | | |
| Daratumumab with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal) | TA454 | | |
| Bortezomib for treating multiple myeloma after second or subsequent relapse (terminated appraisal) | TA453 | | |
| Ibrutinib for untreated chronic lymphocytic leukaemia without a 17p deletion or TP53 mutation (terminated appraisal) | TA452 | | |
| L-Dex U400 for lymphoedema after breast cancer treatment | MIB111 | | |
| Air pollution: outdoor air quality and health | NG70 | | |
| Violent and aggressive behaviours in people with mental health problems | QS154 | | |
| Multimorbidity | QS153 | | |
| Liver disease | QS152 | | |
| Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia | TA451 | | |
| Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia | TA450 | | |
| Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease | TA449 | | |
| Etelcalcetide for treating secondary hyperparathyroidism | TA448 | | |
| Uterine suspension using mesh (including sacrohysteropexy) to repair uterine prolapse | IPG584 | | |
| Sacrocolpopexy using mesh to repair vaginal vault prolapse | IPG583 | | |
| Infracoccygeal sacropexy using mesh to repair uterine prolapse | IPG582 | | |
| Infracoccygeal sacropexy using mesh to repair vaginal vault prolapse | IPG581 | | |
| Eliglustat for treating type 1 Gaucher disease | HST5 | | |
| Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | DG29 | | |
| RIDASCREEN tests for monitoring infliximab in inflammatory bowel disease | MIB109 | | |
| Neo Pedicle Screw System for spinal fusion surgery | MIB108 | | |
| Oral health in care homes | QS151 | | |
| Obesity: working with local communities | PH42 | | |
| SecurAcath for securing cerebrospinal fluid catheters | MIB107 | | |
| Spondyloarthritis in over 16s: diagnosis and management | NG65 | | |
| Haematological cancers | QS150 | | |
| Bindex for investigating suspected osteoporosis | MIB106 | | |
| Certolizumab pegol and secukinumab for treating active psoriatic arthritis after inadequate response to DMARDs | TA445 | | |
| Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal) | TA444 | | |
| Endoscopic full thickness removal of non-lifting colonic polyps | IPG580 | | |
| Permacol for treating anal fistulae | MIB105 | | |
| Idiopathic pulmonary fibrosis in adults: diagnosis and management | CG163 | | |
| NaviCam for diagnosing gastrointestinal tract conditions | MIB104 | | |
| Virtual chromoendoscopy to assess colorectal polyps during colonoscopy | DG28 | | |
| Intravenous fluid therapy in adults in hospital | CG174 | | |
| Hemosep for cell salvage | MIB103 | | |
| Irreversible electroporation for treating pancreatic cancer | IPG579 | | |
| Osteoporosis | QS149 | | |
| Obeticholic acid for treating primary biliary cholangitis | TA443 | | |
| Ixekizumab for treating moderate to severe plaque psoriasis | TA442 | | |
| Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine | TA440 | | |
| VAAFT for treating anal fistulae | MIB102 | | |
| Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
| Alcohol-use disorders: diagnosis and management of physical complications | CG100 | | |
| Sexually transmitted infections: condom distribution schemes | NG68 | | |
| Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac pain | IPG578 | | |
| Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
| Managing medicines for adults receiving social care in the community | NG67 | | |
| Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal) | TA438 | | |
| Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) | TA240 | | |
| Bair Hugger for measuring core temperature during perioperative care | MIB99 | | |
| Mollii suit for spasticity | MIB100 | | |
| Mitochondrial disorders in children: Co-enzyme Q10 | ES11 | | |
| Patient group directions | MPG2 | | |
| Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal) | TA437 | | |
| Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal) | TA436 | | |
| Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) | TA435 | | |
| Elotuzumab for previously treated multiple myeloma (terminated appraisal) | TA434 | | |
| Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse | IPG577 | | |
| Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women | IPG576 | | |
| Mental health of adults in contact with the criminal justice system | NG66 | | |
| Hyperhidrosis: oxybutynin | ES10 | | |
| Narcolepsy with or without cataplexy in adults: pitolisant | ES8 | | |
| SimpliCT laser-guided needle placement in interventional radiology | MIB98 | | |
| TopClosure Tension Relief System for wound closure | MIB97 | | |
| Skin involvement in systemic sclerosis: rituximab | ES7 | | |
| Ustekinumab for treating active psoriatic arthritis | TA340 | | |
| Ustekinumab for the treatment of adults with moderate to severe psoriasis | TA180 | | |
| Community engagement: improving health and wellbeing | QS148 | | |
| Healthy workplaces: improving employee mental and physical health and wellbeing | QS147 | | |
| Head and neck cancer | QS146 | | |
| Care of dying adults in the last days of life | QS144 | | |
| Intrapartum care | QS105 | | |
| Apremilast for treating active psoriatic arthritis | TA433 | | |
| Everolimus for advanced renal cell carcinoma after previous treatment | TA432 | | |
| Drug misuse prevention: targeted interventions | NG64 | | |
| Trabecular stent bypass microsurgery for open-angle glaucoma | IPG575 | | |
| Lateral interbody fusion in the lumbar spine for low back pain | IPG574 | | |
| Migalastat for treating Fabry disease | HST4 | | |
| Molecular testing strategies for Lynch syndrome in people with colorectal cancer | DG27 | | |
| Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
| Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide | ES5 | | |
| Menopause | QS143 | | |
| Smart One for measuring lung function | MIB96 | | |
| U-Drain for people needing night drainage of urine or dialysis fluid | MIB95 | | |
| HumiGard for preventing inadvertent perioperative hypothermia | MTG31 | | |
| eazyplex SuperBug kits for detecting carbapenemase-producing organisms | MIB94 | | |
| Osteoporosis: assessing the risk of fragility fracture | CG146 | | |
| Stable angina | QS21 | | |
| Falls in older people | QS86 | | |
| Sofosbuvir–velpatasvir for treating chronic hepatitis C | TA430 | | |
| Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation | TA429 | | |
| Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
| Cerebral palsy in under 25s: assessment and management | NG62 | | |
| Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis | MIB93 | | |
| CentriMag for heart failure | MIB92 | | |
| Boston Keratoprosthesis Type I for corneal blindness | MIB91 | | |
| Refractory extrapulmonary sarcoidosis: infliximab | ES4 | | |
| Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib | TA427 | | |
| Smartinhaler for asthma | MIB90 | | |
| Learning disability: identifying and managing mental health problems | QS142 | | |
| Tuberculosis | QS141 | | |
| Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia | TA426 | | |
| Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia | TA425 | | |
| Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | TA424 | | |
| Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens | TA423 | | |
| Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA422 | | |
| Everolimus with exemestane for treating advanced breast cancer after endocrine therapy | TA421 | | |
| Radiation therapy for early Dupuytren's disease | IPG573 | | |
| Extracorporeal shockwave therapy for Achilles tendinopathy | IPG571 | | |
| Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation | CG135 | | |
| Pulmonary sarcoidosis: infliximab | ES2 | | |
| Oral health promotion in the community | QS139 | | |
| Blood transfusion | QS138 | | |
| Ticagrelor for preventing atherothrombotic events after myocardial infarction | TA420 | | |
| Epiduroscopic lumbar discectomy through the sacral hiatus for sciatica | IPG570 | | |
| Hypothermia: prevention and management in adults having surgery | CG65 | | |
| XprESS multi sinus dilation system for treating chronic sinusitis | MTG30 | | |
| CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes | MIB48 | | |
| Mental wellbeing and independence for older people | QS137 | | |
| Transition between inpatient hospital settings and community or care home settings for adults with social care needs | QS136 | | |
| HIV testing: increasing uptake among people who may have undiagnosed HIV | NG60 | | |
| Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
| Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis | CG95 | | |
| Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions | MIB89 | | |
| Sternal Talon for sternal closure in cardiothoracic surgery | MIB88 | | |
| CytoSorb therapy for sepsis | MIB87 | | |
| OCS Heart system for heart transplant | MIB86 | | |
| Spasticity in under 19s: management | CG145 | | |
| Apremilast for treating moderate to severe plaque psoriasis | TA419 | | |
| Dapagliflozin in triple therapy for treating type 2 diabetes | TA418 | | |
| Nivolumab for previously treated advanced renal cell carcinoma | TA417 | | |
| Dapagliflozin in combination therapy for treating type 2 diabetes | TA288 | | |
| Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity | IPG569 | | |
| Percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture | IPG568 | | |
| Endoscopic transluminal pancreatic necrosectomy | IPG567 | | |
| High-throughput non-invasive prenatal testing for fetal RHD genotype | DG25 | | |
| Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab | ES1 | | |
| Physical health of people in prison | NG57 | | |
| Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor | TA415 | | |
| Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma | TA414 | | |
| Elbasvir–grazoprevir for treating chronic hepatitis C | TA413 | | |
| Needle-free arterial non-injectable connector | MIB85 | | |
| Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
| Coeliac disease | QS134 | | |
| Children's attachment | QS133 | | |
| Single-incision short sling mesh insertion for stress urinary incontinence in women | IPG566 | | |
| Woundchek Protease Status for assessing elevated protease status in chronic wounds | MIB83 | | |
| Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases | TA412 | | |
| Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer | TA411 | | |
| Talimogene laherparepvec for treating unresectable metastatic melanoma | TA410 | | |
| Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion | TA409 | | |
| Pegaspargase for treating acute lymphoblastic leukaemia | TA408 | | |
| Secukinumab for active ankylosing spondylitis after treatment with non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors | TA407 | | |
| Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA406 | | |
| Miniature lens system implantation for advanced age-related macular degeneration | IPG565 | | |
| Social care for older people with multiple long-term conditions | QS132 | | |
| Intravenous fluid therapy in children and young people in hospital | QS131 | | |
| Multimorbidity: clinical assessment and management | NG56 | | |
| Harmful sexual behaviour among children and young people | NG55 | | |
| Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
| Alere Afinion CRP for C-reactive protein testing in primary care | MIB81 | | |
| FLEXISEQ for osteoarthritis | MIB80 | | |
| QuikRead go for C-reactive protein testing in primary care | MIB78 | | |
| Contraception | QS129 | | |
| Transition between inpatient mental health settings and community or care home settings | NG53 | | |
| Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
| Stable angina: management | CG126 | | |
| Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel | TA391 | | |
| Trifluridine–tipiracil for previously treated metastatic colorectal cancer | TA405 | | |
| Degarelix for treating advanced hormone-dependent prostate cancer | TA404 | | |
| Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer | TA403 | | |
| Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin | TA402 | | |
| Bosutinib for previously treated chronic myeloid leukaemia | TA401 | | |
| OSNA for colon cancer staging | MIB77 | | |
| Axxent electronic brachytherapy system for early stage breast cancer | MIB76 | | |
| Early years: promoting health and wellbeing in under 5s | QS128 | | |
| Obesity: clinical assessment and management | QS127 | | |
| Palliative care for adults: strong opioids for pain relief | CG140 | | |
| Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated | TA387 | | |
| Nivolumab in combination with ipilimumab for treating advanced melanoma | TA400 | | |
| Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts | TA399 | | |
| Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutation | TA398 | | |
| Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen | TA259 | | |
| Motor neurone disease | QS126 | | |
| Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation | IPG563 | | |
| Stretta System for gastro-oesophageal reflux disease | MIB74 | | |
| QTUG for assessing falls risk and frailty | MIB73 | | |
| Non-Hodgkin's lymphoma: diagnosis and management | NG52 | | |
| Alair bronchial thermoplasty system for adults with severe difficult to control asthma | MIB71 | | |
| Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
| Non-alcoholic fatty liver disease (NAFLD): assessment and management | NG49 | | |
| Oral health for adults in care homes | NG48 | | |
| Mobi-C for cervical disc replacement | MIB70 | | |
| Cellvizio confocal endomicroscopy system for characterising pancreatic cysts | MIB69 | | |
| Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma | TA396 | | |
| Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer | TA395 | | |
| Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA394 | | |
| Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA393 | | |
| Adalimumab for treating moderate to severe hidradenitis suppurativa | TA392 | | |
| Home care for older people | QS123 | | |
| Bronchiolitis in children | QS122 | | |
| Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules | IPG562 | | |
| Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting | IPG561 | | |
| Microstructural scaffold (patch) insertion without autologous cell implantation for repairing symptomatic chondral knee defects | IPG560 | | |
| Breast cancer | QS12 | | |
| S-Cath System for suprapubic catheterisation | MIB68 | | |
| Complicated urinary tract infections: ceftolozane/tazobactam | ESNM74 | | |
| Complicated intra-abdominal infections: ceftolozane/tazobactam | ESNM75 | | |
| Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes | TA390 | | |
| Haematological cancers: improving outcomes | NG47 | | |
| Endovenous mechanochemical ablation for varicose veins | IPG557 | | |
| Prolaris gene expression assay for assessing long-term risk of prostate cancer progression | MIB65 | | |
| CareLink network service for remote monitoring of people with cardiac devices | MIB64 | | |
| LATITUDE NXT Patient Management System for monitoring cardiac devices at home | MIB67 | | |
| Secca System for faecal incontinence | MIB66 | | |
| Reversal of the anticoagulant effect of dabigatran: idarucizumab | ESNM73 | | |
| ImmunoCAP ISAC 112 for multiplex allergen testing | DG24 | | |
| Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer | TA389 | | |
| Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction | TA388 | | |
| Microwave ablation for treating liver metastases | IPG553 | | |
| Percutaneous transforaminal endoscopic lumbar discectomy for sciatica | IPG556 | | |
| Percutaneous interlaminar endoscopic lumbar discectomy for sciatica | IPG555 | | |
| Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension | IPG554 | | |
| Antimicrobial stewardship | QS121 | | |
| Stroke in adults | QS2 | | |
| Controlled drugs: safe use and management | NG46 | | |
| Routine preoperative tests for elective surgery | NG45 | | |
| Chronic wounds: advanced wound dressings and antimicrobial dressings | ESMPB2 | | |
| Medicines optimisation | QS120 | | |
| Anaphylaxis | QS119 | | |
| Food allergy | QS118 | | |
| Workplace health: management practices | NG13 | | |
| Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis | TA386 | | |
| ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation | MIB61 | | |
| TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation | MIB60 | | |
| Transcutaneous stimulation of the cervical branch of the vagus nerve for cluster headache and migraine | IPG552 | | |
| Corticosteroid-eluting bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis | IPG551 | | |
| Endoscopic carbon dioxide laser cricopharyngeal myotomy for relief of oropharyngeal dysphagia | IPG550 | | |
| Otovent nasal balloon for otitis media with effusion | MIB59 | | |
| Mersey Burns for calculating fluid resuscitation volume when managing burns | MIB58 | | |
| Icare rebound tonometer to measure intraocular pressure | MIB57 | | |
| ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot | MIB56 | | |
| ClearWay RX for drug delivery to coronary artery thrombotic lesions | MIB55 | | |
| Preventing excess winter deaths and illness associated with cold homes | QS117 | | |
| Community engagement: improving health and wellbeing and reducing health inequalities | NG44 | | |
| Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) | TA23 | | |
| Spectra Optia for automatic red blood cell exchange in people with sickle cell disease | MTG28 | | |
| Prevention of chemotherapy induced nausea and vomiting in adults: netupitant/palonosetron | ESNM69 | | |
| Domestic violence and abuse | QS116 | | |
| Ezetimibe for treating primary heterozygous-familial and non-familial hypercholesterolaemia | TA385 | | |
| Transition from children's to adults' services for young people using health or social care services | NG43 | | |
| Normothermic extracorporeal preservation of hearts for transplantation following donation after brainstem death | IPG549 | | |
| Mechanical clot retrieval for treating acute ischaemic stroke | IPG548 | | |
| Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction | IPG546 | | |
| Nivolumab for treating advanced (unresectable or metastatic) melanoma | TA384 | | |
| Bipolar disorder in adults | QS95 | | |
| Antenatal and postnatal mental health | QS115 | | |
| Major trauma: assessment and initial management | NG39 | | |
| Fractures (non-complex): assessment and management | NG38 | | |
| Spinal injury: assessment and initial management | NG41 | | |
| Major trauma: service delivery | NG40 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | DG22 | | |
| Xpert Carba-R to identify people carrying carbapenemase-producing organisms | MIB52 | | |
| MiniMed 640G system with SmartGuard for managing blood glucose levels in people with type 1 diabetes | MIB51 | | |
| Irritable bowel syndrome in adults | QS114 | | |
| Healthcare-associated infections | QS113 | | |
| Skin cancer prevention | PH32 | | |
| Sunlight exposure: risks and benefits | NG34 | | |
| TNF-alpha inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis | TA383 | | |
| Gastro-oesophageal reflux in children and young people | QS112 | | |
| Eltrombopag for treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal) | TA382 | | |
| Panobinostat for treating multiple myeloma after at least 2 previous treatments | TA380 | | |
| Nintedanib for treating idiopathic pulmonary fibrosis | TA379 | | |
| Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy | TA378 | | |
| Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated | TA377 | | |
| Percutaneous intradiscal radiofrequency treatment of the intervertebral disc nucleus for low back pain | IPG545 | | |
| Percutaneous electrothermal treatment of the intervertebral disc annulus for low back pain and sciatica | IPG544 | | |
| Percutaneous coblation of the intervertebral disc for low back pain and sciatica | IPG543 | | |
| Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed | TA375 | | |
| BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume | MIB50 | | |
| EarlySense for heart and respiratory monitoring and predicting patient deterioration | MIB49 | | |
| Guidance on the use of imatinib for chronic myeloid leukaemia | TA70 | | |
| Obesity in adults: prevention and lifestyle weight management programmes | QS111 | | |
| Pneumonia in adults | QS110 | | |
| Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g cream | ESNM68 | | |
| Multiple sclerosis | QS108 | | |
| Preventing unintentional injury in under 15s | QS107 | | |
| C3 glomerulopathy in the native kidney: eculizumab | ESUOM49 | | |
| Bladder cancer | QS106 | | |
| Older people: independence and mental wellbeing | NG32 | | |
| Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapy | TA374 | | |
| Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis | TA373 | | |
| Bortezomib for previously untreated mantle cell lymphoma | TA370 | | |
| Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears | TA369 | | |
| Care of dying adults in the last days of life | NG31 | | |
| Repetitive transcranial magnetic stimulation for depression | IPG542 | | |
| Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux disease | IPG540 | | |
| Radiofrequency ablation for symptomatic interdigital (Morton's) neuroma | IPG539 | | |
| Joint distraction for ankle osteoarthritis | IPG538 | | |
| Insertion of a subretinal prosthesis system for retinitis pigmentosa | IPG537 | | |
| Oral health promotion: general dental practice | NG30 | | |
| TearLab osmolarity system for diagnosing dry eye disease | MIB47 | | |
| AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis | MIB46 | | |
| Restless legs syndrome: Oxycodone/naloxone prolonged release | ESNM67 | | |
| External genital and perianal warts: green tea (Camellia sinensis) leaf extract 10% ointment | ESNM66 | | |
| Gallstone disease | QS104 | | |
| Acute heart failure | QS103 | | |
| Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo) | ESNM65 | | |
| Diabetes mellitus type 1 and type 2: insulin glargine biosimilar (Abasaglar) | ESNM64 | | |
| Transition between inpatient hospital settings and community or care home settings for adults with social care needs | NG27 | | |
| Vortioxetine for treating major depressive episodes | TA367 | | |
| Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C | TA365 | | |
| Ledipasvir–sofosbuvir for treating chronic hepatitis C | TA363 | | |
| Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
| Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention | IPG536 | | |
| Living-donor liver transplantation | IPG535 | | |
| Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes | IPG534 | | |
| Blood transfusion | NG24 | | |
| VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions | DG19 | | |
| ATEC system for vacuum-assisted breast biopsy | MIB43 | | |
| Older people with social care needs and multiple long-term conditions | NG22 | | |
| Coronary revascularisation: Cangrelor | ESNM63 | | |
| Paclitaxel as albumin-bound nanoparticles with carboplatin for untreated non-small-cell lung cancer (terminated appraisal) | TA362 | | |
| Idelalisib for treating chronic lymphocytic leukaemia | TA359 | | |
| Tolvaptan for treating autosomal dominant polycystic kidney disease | TA358 | | |
| Developing and updating local formularies | MPG1 | | |
| Implanting a baroreceptor stimulation device for resistant hypertension | IPG533 | | |
| Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset | NG16 | | |
| Bipolar disorder, psychosis and schizophrenia in children and young people | QS102 | | |
| PROPATEN heparin-bonded vascular graft for peripheral arterial disease | MIB42 | | |
| Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) | DG18 | | |
| Orthostatic hypotension due to autonomic dysfunction: midodrine | ESNM61 | | |
| Active B12 assay for diagnosing vitamin B12 deficiency | MIB40 | | |
| ERBE flexible cryoprobes for bronchoscopic diagnosis and treatment | MIB39 | | |
| Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer | IPG532 | | |
| Home care: delivering personal care and practical support to older people living in their own homes | NG21 | | |
| i STAT CG4+ and CHEM8+ cartridges for point-of-care testing in the emergency department | MIB38 | | |
| Thermogard XP for therapeutic hypothermia after cardiac arrest | MIB37 | | |
| Secondary prevention after a myocardial infarction | QS99 | | |
| Coeliac disease: recognition, assessment and management | NG20 | | |
| Hypertension in adults | QS28 | | |
| Edoxaban for treating and for preventing deep vein thrombosis and pulmonary embolism | TA354 | | |
| Bevacizumab for treating relapsed, platinum‑resistant epithelial ovarian, fallopian tube or primary peritoneal cancer (terminated appraisal) | TA353 | | |
| Vedolizumab for treating moderately to severely active Crohn's disease after prior therapy | TA352 | | |
| Preoperative high dose rate brachytherapy for rectal cancer | IPG531 | | |
| Transcranial direct current stimulation (tDCS) for depression | IPG530 | | |
| Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use | NG15 | | |
| Infantile haemangioma: topical timolol | ESUOM47 | | |
| Visensia for early detection of deteriorating vital signs in adults in hospital | MIB36 | | |
| Drug allergy | QS97 | | |
| Obesity in children and young people: prevention and lifestyle weight management programmes | QS94 | | |
| Dyspepsia and gastro‑oesophageal reflux disease in adults | QS96 | | |
| Joint distraction for knee osteoarthritis without alignment correction | IPG529 | | |
| Insertion of a double balloon catheter for induction of labour in pregnant women without previous caesarean section | IPG528 | | |
| Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal) | TA351 | | |
| Secukinumab for treating moderate to severe plaque psoriasis | TA350 | | |
| Everolimus for preventing organ rejection in liver transplantation | TA348 | | |
| Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancer | TA347 | | |
| Aflibercept for treating diabetic macular oedema | TA346 | | |
| Naloxegol for treating opioid‑induced constipation | TA345 | | |
| BD MAX Enteric Bacterial Panel for identifying pathogens in contagious gastroenteritis | MIB32 | | |
| Spiral Flow peripheral vascular graft for treating peripheral arterial disease | MIB34 | | |
| Hypersexuality: fluoxetine | ESUOM46 | | |
| Type 2 diabetes: insulin degludec/liraglutide (Xultophy) | ESNM60 | | |
| Nutrition: improving maternal and child nutrition | QS98 | | |
| Symptoms of peripheral arterial disease: ramipril | ESUOM45 | | |
| Insertion of an epiretinal prosthesis for retinitis pigmentosa | IPG519 | | |
| Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headache | IPG527 | | |
| Electrotherapy for the treatment of haemorrhoids | IPG525 | | |
| Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism | IPG524 | | |
| Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis | IPG523 | | |
| Suture fixation of acute disruption of the distal tibiofibular syndesmosis | IPG521 | | |
| Radiofrequency ablation for gastric antral vascular ectasia | IPG520 | | |
| Prevention of recurrence of C3 glomerulopathy post-transplant: eculizumab | ESUOM44 | | |
| Pressure ulcers | QS89 | | |
| Personality disorders: borderline and antisocial | QS88 | | |
| Omalizumab for previously treated chronic spontaneous urticaria | TA339 | | |
| Vedolizumab for treating moderately to severely active ulcerative colitis | TA342 | | |
| Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism | TA341 | | |
| Lower urinary tract symptoms in men: management | CG97 | | |
| Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia | TA343 | | |
| Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges | NG11 | | |
| Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
| Peptest for diagnosing gastro‑oesophageal reflux | MIB31 | | |
| LARS for reconstructing damaged intra-articular cruciate knee ligaments | MIB30 | | |
| Xpert GBS test for the intrapartum detection of group B streptococcus | MIB28 | | |
| LipiFlow thermal pulsation treatment for dry eyes caused by blocked meibomian glands | MIB29 | | |
| Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes | IPG518 | | |
| Insertion of endobronchial nitinol coils to improve lung function in emphysema | IPG517 | | |
| Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation | IPG516 | | |
| Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section | IPG515 | | |
| Rifaximin for preventing episodes of overt hepatic encephalopathy | TA337 | | |
| Empagliflozin in combination therapy for treating type 2 diabetes | TA336 | | |
| Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome | TA335 | | |
| Medicines management in care homes | QS85 | | |
| Physical activity: for NHS staff, patients and carers | QS84 | | |
| Alcohol: preventing harmful use in the community | QS83 | | |
| Smoking: reducing and preventing tobacco use | QS82 | | |
| The PediGuard for placing pedicle screws in spinal surgery | MIB26 | | |
| The Juxta CURES adjustable compression system for treating venous leg ulcers | MIB25 | | |
| Digital ulcers: sildenafil | ESUOM42 | | |
| Clostridium difficile infection: risk with broad-spectrum antibiotics | ESMPB1 | | |
| Preventing excess weight gain | NG7 | | |
| Obesity prevention | CG43 | | |
| Excess winter deaths and illness and the health risks associated with cold homes | NG6 | | |
| Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | NG5 | | |
| The Epidrum for aiding access to the epidural space | MIB23 | | |
| The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies | MIB24 | | |
| Shiley Endotracheal Tube with TaperGuard Cuff for intensive care patients at risk of ventilator‑associated pneumonia | MIB22 | | |
| VibraTip for testing vibration perception to detect diabetic peripheral neuropathy | MTG22 | | |
| Safe midwifery staffing for maternity settings | NG4 | | |
| Inflammatory bowel disease | QS81 | | |
| Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal) | TA334 | | |
| Axitinib for treating advanced renal cell carcinoma after failure of prior systemic treatment | TA333 | | |
| Sofosbuvir for treating chronic hepatitis C | TA330 | | |
| Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy | TA329 | | |
| Bladder cancer: diagnosis and management | NG2 | | |
| Flexible endoscopic treatment of a pharyngeal pouch | IPG513 | | |
| Psychosis and schizophrenia in adults | QS80 | | |
| The SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of the biliary system | MIB21 | | |
| The Arrow OnControl powered bone marrow biopsy system for bone marrow aspiration and biopsy | MIB19 | | |
| The AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation | MIB18 | | |
| Autoimmune haemolytic anaemia: rituximab | ESUOM39 | | |
| Idiopathic pulmonary fibrosis in adults | QS79 | | |
| Sarcoma | QS78 | | |
| Eculizumab for treating atypical haemolytic uraemic syndrome | HST1 | | |
| Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis | IPG512 | | |
| Open reduction of slipped capital femoral epiphysis | IPG511 | | |
| Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage | IPG510 | | |
| Hysteroscopic metroplasty of a uterine septum for primary infertility | IPG509 | | |
| Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation‑positive malignant melanoma | TA269 | | |
| Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism | TA327 | | |
| Single‑incision laparoscopic cholecystectomy | IPG508 | | |
| The Space GlucoseControl system for managing blood‑glucose in critically ill patients in intensive care | MIB17 | | |
| Aixplorer ShearWave Elastography for ultrasound imaging and assessing suspicious breast lesions | MIB15 | | |
| The Oncentra Prostate v4.x for ultrasound‑guided real‑time HDR brachytherapy in men with localised prostate cancer | MIB16 | | |
| Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment | DG16 | | |
| Erectile dysfunction: Alprostadil cream | ESNM50 | | |
| Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula | IPG507 | | |
| Insertion of an annular disc implant at lumbar discectomy | IPG506 | | |
| Telemetric adjustable pulmonary artery banding for pulmonary hypertension in infants with congenital heart defects | IPG505 | | |
| Imatinib for the adjuvant treatment of gastrointestinal stromal tumours | TA326 | | |
| Nalmefene for reducing alcohol consumption in people with alcohol dependence | TA325 | | |
| Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block | TA324 | | |
| Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy | TA323 | | |
| The OSCAR 3 ultrasonic arthroplasty revision instrument for removing bone cement during prosthetic joint revision | MIB13 | | |
| Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds | MIB11 | | |
| The SENSIMED Triggerfish contact lens sensor for continuous 24-hour recording of ocular dimensional changes in people with or at risk of developing glaucoma | MIB14 | | |
| The NxStage System One NX1000‑1 home haemodialysis device for renal replacement therapy in chronic kidney disease | MIB12 | | |
| The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury | MTG21 | | |
| Dual‑chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block | TA88 | | |
| Maternal and child nutrition | PH11 | | |
| Gallstone disease: diagnosis and management | CG188 | | |
| Fertility problems | QS73 | | |
| Dabrafenib for treating unresectable or metastatic BRAF V600 mutation‑positive melanoma | TA321 | | |
| Oral health: local authorities and partners | PH55 | | |
| Immune (idiopathic) thrombocytopenic purpura: rituximab | ESUOM35 | | |
| Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence | CG115 | | |
| Management of vomiting in children and young people with gastroenteritis: ondansetron | ESUOM34 | | |
| Transient loss of consciousness ('blackouts') in over 16s | QS71 | | |
| Migraine prophylaxis: flunarizine | ESUOM33 | | |
| Promoting tolerance of enteral feeds in children and young people: domperidone | ESUOM18 | | |
| Combined endoscopic and laparoscopic removal of colonic polyps | IPG503 | | |
| Physical activity: exercise referral schemes | PH54 | | |
| Schizophrenia: lurasidone | ESNM48 | | |
| Bedwetting in children and young people | QS70 | | |
| End-tidal Control software for use with Aisys closed circuit anaesthesia systems for automated gas control during general anaesthesia | MIB10 | | |
| Ectopic pregnancy and miscarriage | QS69 | | |
| Non-Hodgkin's lymphoma: rituximab subcutaneous injection | ESNM46 | | |
| Drug allergy: diagnosis and management | CG183 | | |
| Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis | TA320 | | |
| Total prosthetic replacement of the temporomandibular joint | IPG500 | | |
| The PolySoft hernia patch used with the ONSTEP technique to treat inguinal hernias | MIB9 | | |
| Assessing motility of the gastrointestinal tract using a wireless capsule | IPG502 | | |
| Minimally invasive video‑assisted parathyroidectomy | IPG501 | | |
| Minimally invasive video-assisted thyroidectomy | IPG499 | | |
| Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) | DG13 | | |
| Varicose veins in the legs | QS67 | | |
| Intravenous fluid therapy in adults in hospital | QS66 | | |
| Erectile dysfunction: avanafil | ESNM45 | | |
| The Airsonett temperature-controlled laminar airflow device for persistent allergic asthma | MIB8 | | |
| The hTEE system for transoesophageal echocardiographic monitoring of haemodynamic instability | MIB7 | | |
| Hepatitis B | QS65 | | |
| Delirium in adults | QS63 | | |
| Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma | TA319 | | |
| Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes | TA317 | | |
| Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen | TA316 | | |
| Powered microdebrider turbinoplasty for inferior turbinate hypertrophy | IPG498 | | |
| Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus | IPG497 | | |
| Endoscopic radiofrequency ablation for Barrett's oesophagus with low‑grade dysplasia or no dysplasia | IPG496 | | |
| Safe staffing for nursing in adult inpatient wards in acute hospitals | SG1 | | |
| Chronic urticaria: off-label doses of cetirizine | ESUOM31 | | |
| Facial erythema of rosacea: brimonidine tartrate gel | ESNM43 | | |
| Canagliflozin in combination therapy for treating type 2 diabetes | TA315 | | |
| Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure | TA314 | | |
| The geko device for reducing the risk of venous thromboembolism | MTG19 | | |
| Radiofrequency tissue reduction for turbinate hypertrophy | IPG495 | | |
| Endoscopic saphenous vein harvest for coronary artery bypass grafting | IPG494 | | |
| AccuVein AV400 for vein visualisation | MIB6 | | |
| Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus | MIB5 | | |
| Teriflunomide for treating relapsing–remitting multiple sclerosis | TA303 | | |
| Weight management: lifestyle services for overweight or obese adults | PH53 | | |
| Gastroelectrical stimulation for gastroparesis | IPG489 | | |
| Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee | IPG493 | | |
| Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb | IPG487 | | |
| Premature ejaculation: dapoxetine | ESNM40 | | |
| Constipation in children and young people | QS62 | | |
| Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation | TA311 | | |
| Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer | TA310 | | |
| Pressure ulcers: prevention and management | CG179 | | |
| Infection prevention and control | QS61 | | |
| Antisocial behaviour and conduct disorders in children and young people | QS59 | | |
| Sickle cell disease | QS58 | | |
| Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | DG12 | | |
| Insertion of a magnetic bead band for faecal incontinence | IPG483 | | |
| Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults | IPG482 | | |
| Faecal microbiota transplant for recurrent Clostridium difficile infection | IPG485 | | |
| Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancy | IPG484 | | |
| Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis | TA308 | | |
| Needle and syringe programmes | PH52 | | |
| Contraceptive services for under 25s | PH51 | | |
| Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy | TA307 | | |
| Pouchitis: rifaximin | ESUOM30 | | |
| Difficult-to-treat scabies: oral ivermectin | ESUOM29 | | |
| Managing medicines in care homes | SC1 | | |
| Jaundice in newborn babies under 28 days | QS57 | | |
| Psychosis and schizophrenia in adults: prevention and management | CG178 | | |
| Cancer services for children and young people | QS55 | | |
| Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma | TA306 | | |
| Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion | TA305 | | |
| Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip | TA304 | | |
| Domestic violence and abuse: multi-agency working | PH50 | | |
| Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma | IPG478 | | |
| Optical coherence tomography to guide percutaneous coronary intervention | IPG481 | | |
| Endoscopic thoracic sympathectomy for primary facial blushing | IPG480 | | |
| Faecal incontinence in adults | QS54 | | |
| Anxiety disorders | QS53 | | |
| The NGAL Test for early diagnosis of acute kidney injury | MIB3 | | |
| The PressureWire fractional flow reserve measurement system for coronary artery disease | MIB2 | | |
| The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns | MIB1 | | |
| The RhinoChill intranasal cooling system for reducing temperature after cardiac arrest | MIB4 | | |
| Transcranial magnetic stimulation for treating and preventing migraine | IPG477 | | |
| Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia | IPG475 | | |
| Arthroscopic trochleoplasty for patellar instability | IPG474 | | |
| Radiofrequency ablation of the soft palate for snoring | IPG476 | | |
| Peripheral arterial disease | QS52 | | |
| Autism | QS51 | | |
| Behaviour change: individual approaches | PH49 | | |
| Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events | IPG472 | | |
| Combined oral contraception: nomegestrol/estradiol (Zoely) | ESNM28 | | |
| Uterine artery embolisation for treating adenomyosis | IPG473 | | |
| Mental wellbeing of older people in care homes | QS50 | | |
| Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal) | TA302 | | |
| Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people | TA300 | | |
| Implantation of a duodenal–jejunal bypass sleeve for managing obesity | IPG471 | | |
| Phrenic nerve transfer in brachial plexus injury | IPG468 | | |
| Negative pressure wound therapy for the open abdomen | IPG467 | | |
| Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C | TA75 | | |
| Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C | TA106 | | |
| Surgical site infection | QS49 | | |
| Bile acid malabsorption: colesevelam | ESUOM22 | | |
| Weight management: lifestyle services for overweight or obese children and young people | PH47 | | |
| Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment | ESUOM21 | | |
| Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel | DG11 | | |
| Postural hypotension in adults: fludrocortisone | ESUOM20 | | |
| Depression in children and young people | QS48 | | |
| Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus and keratectasia | IPG466 | | |
| Schizophrenia: omega-3 fatty acid medicines | ESUOM19 | | |
| Lower urinary tract symptoms in men | QS45 | | |
| Type 2 diabetes: insulin degludec | ESNM25 | | |
| Atopic eczema in under 12s | QS44 | | |
| Headaches in over 12s | QS42 | | |
| Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease | IPG461 | | |
| Translaryngeal tracheostomy | IPG462 | | |
| EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | DG9 | | |
| Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | DG8 | | |
| Psoriasis | QS40 | | |
| Pazopanib for the first-line treatment of advanced renal cell carcinoma | TA215 | | |
| Acute upper gastrointestinal bleeding in adults | QS38 | | |
| Aflibercept solution for injection for treating wet age‑related macular degeneration | TA294 | | |
| Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder | TA292 | | |
| Varicose veins: diagnosis and management | CG168 | | |
| Selective internal radiation therapy for primary hepatocellular carcinoma | IPG460 | | |
| Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction | IPG457 | | |
| Hyperhidrosis: oral glycopyrronium bromide | ESUOM16 | | |
| Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction | IPG449 | | |
| Mirabegron for treating symptoms of overactive bladder | TA290 | | |
| Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism | TA287 | | |
| Chronic anal fissure: botulinum toxin type A injection | ESUOM14 | | |
| Gastroparesis in adults: oral erythromycin | ESUOM13 | | |
| Falls in older people: assessing risk and prevention | CG161 | | |
| Physical activity: brief advice for adults in primary care | PH44 | | |
| Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) | TA286 | | |
| Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer | TA285 | | |
| Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer | TA284 | | |
| Social anxiety disorder: recognition, assessment and treatment | CG159 | | |
| Corneal inlay implantation for correction of presbyopia | IPG455 | | |
| Occipital nerve stimulation for intractable chronic migraine | IPG452 | | |
| Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures | TA279 | | |
| Omalizumab for treating severe persistent allergic asthma | TA278 | | |
| Looked-after children and young people | QS31 | | |
| Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) | TA277 | | |
| Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis | TA276 | | |
| Peripheral nerve-field stimulation for chronic low back pain | IPG451 | | |
| Percutaneous electrical nerve stimulation for refractory neuropathic pain | IPG450 | | |
| Insertion of endobronchial valves for persistent air leaks | IPG448 | | |
| Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma | IPG446 | | |
| Antisocial personality disorder: prevention and management | CG77 | | |
| Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment | ESUOM7 | | |
| Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab | ESNM13 | | |
| Hepatitis B and C testing: people at risk of infection | PH43 | | |
| Irreversible electroporation for treating liver metastases | IPG445 | | |
| Irreversible electroporation for treating renal cancer | IPG443 | | |
| Irreversible electroporation for treating primary lung cancer and metastases in the lung | IPG441 | | |
| Ultrasound-guided foam sclerotherapy for varicose veins | IPG440 | | |
| Polycystic ovary syndrome: metformin in women not planning pregnancy | ESUOM6 | | |
| Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate | ESUOM4 | | |
| Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) | TA273 | | |
| Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract | TA272 | | |
| Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy | IPG439 | | |
| Autologous blood injection for tendinopathy | IPG438 | | |
| Autologous blood injection for plantar fasciitis | IPG437 | | |
| Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction | IPG436 | | |
| Chronic anal fissure: 2% topical diltiazem hydrochloride | ESUOM3 | | |
| Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal) | TA270 | | |
| Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma | TA268 | | |
| Dronedarone for the treatment of non-permanent atrial fibrillation | TA197 | | |
| Nutrition support in adults | QS24 | | |
| Ivabradine for treating chronic heart failure | TA267 | | |
| Mannitol dry powder for inhalation for treating cystic fibrosis | TA266 | | |
| Physical activity: walking and cycling | PH41 | | |
| Radiofrequency cold ablation for respiratory papillomatosis | IPG434 | | |
| Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease | IPG433 | | |
| Laparoscopic gastric plication for the treatment of severe obesity | IPG432 | | |
| Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | DG6 | | |
| Drug use disorders in adults | QS23 | | |
| Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours | TA265 | | |
| Social and emotional wellbeing: early years | PH40 | | |
| Alteplase for treating acute ischaemic stroke | TA264 | | |
| Neutropenic sepsis: prevention and management in people with cancer | CG151 | | |
| SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver | DG5 | | |
| Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer | TA263 | | |
| Mega Soft Patient Return Electrode for use during monopolar electrosurgery | MTG11 | | |
| Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism | TA261 | | |
| Partial replacement of the meniscus of the knee using a biodegradable scaffold | IPG430 | | |
| Endovascular stent insertion for intracranial atherosclerotic disease | IPG429 | | |
| Botulinum toxin type A for the prevention of headaches in adults with chronic migraine | TA260 | | |
| Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer | TA258 | | |
| Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2 | TA257 | | |
| Sickle cell disease: managing acute painful episodes in hospital | CG143 | | |
| Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation | IPG427 | | |
| Ovarian cancer | QS18 | | |
| Micropressure therapy for refractory Ménière's disease | IPG426 | | |
| Focal therapy using cryoablation for localised prostate cancer | IPG423 | | |
| Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis | TA254 | | |
| Incisionless otoplasty | IPG422 | | |
| Tocilizumab for the treatment of rheumatoid arthritis | TA247 | | |
| Pharmalgen for the treatment of bee and wasp venom allergy | TA246 | | |
| Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults | TA245 | | |
| Rituximab for the first-line treatment of stage III-IV follicular lymphoma | TA243 | | |
| Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy: Cetuximab (monotherapy or combination chemotherapy), bevacizumab (in combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy | TA242 | | |
| Breast reconstruction using lipomodelling after breast cancer treatment | IPG417 | | |
| Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer | TA118 | | |
| Epiretinal brachytherapy for wet age-related macular degeneration | IPG415 | | |
| Fulvestrant for the treatment of locally advanced or metastatic breast cancer | TA239 | | |
| Tocilizumab for the treatment of systemic juvenile idiopathic arthritis | TA238 | | |
| Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services | CG136 | | |
| Single-port laparoscopic nephrectomy | IPG414 | | |
| Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids | IPG413 | | |
| Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants | IPG412 | | |
| Healthcare-associated infections: prevention and control | PH36 | | |
| Ticagrelor for the treatment of acute coronary syndromes | TA236 | | |
| Mifamurtide for the treatment of osteosarcoma | TA235 | | |
| The EOS 2D/3D imaging system | DG1 | | |
| Arthroscopic femoro–acetabular surgery for hip impingement syndrome | IPG408 | | |
| Minimally invasive oesophagectomy | IPG407 | | |
| Laparoscopic cryotherapy for renal cancer | IPG405 | | |
| Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion | TA229 | | |
| Bortezomib and thalidomide for the first‑line treatment of multiple myeloma | TA228 | | |
| Agomelatine for the treatment of major depressive episodes (terminated appraisal) | TA231 | | |
| Open femoro–acetabular surgery for hip impingement syndrome | IPG403 | | |
| Percutaneous cryotherapy for renal cancer | IPG402 | | |
| Ambulight PDT for the treatment of non-melanoma skin cancer | MTG6 | | |
| The MIST Therapy system for the promotion of wound healing | MTG5 | | |
| Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction | TA73 | | |
| Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer | TA227 | | |
| Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma | TA226 | | |
| Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs | TA225 | | |
| Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism | IPG400 | | |
| Endoscopic radical inguinal lymphadenectomy | IPG398 | | |
| Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease | TA223 | | |
| Trabeculotomy ab interno for open angle glaucoma | IPG397 | | |
| Percutaneous tibial nerve stimulation for faecal incontinence | IPG395 | | |
| Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence | IPG393 | | |
| Type 2 diabetes prevention: population and community-level interventions | PH35 | | |
| Golimumab for the treatment of psoriatic arthritis | TA220 | | |
| Stent insertion for bleeding oesophageal varices | IPG392 | | |
| Extracorporeal membrane oxygenation for severe acute respiratory failure in adults | IPG391 | | |
| Endovascular stent-grafting of popliteal aneurysms | IPG390 | | |
| Carotid artery stent placement for symptomatic extracranial carotid stenosis | IPG389 | | |
| Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia | TA218 | | |
| Deep brain stimulation for intractable trigeminal autonomic cephalalgias | IPG381 | | |
| Laser correction of refractive error following non-refractive ophthalmic surgery | IPG385 | | |
| Percutaneous retroperitoneal endoscopic necrosectomy | IPG384 | | |
| Hand allotransplantation | IPG383 | | |
| Deep brain stimulation for refractory chronic pain syndromes (excluding headache) | IPG382 | | |
| Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings | CG120 | | |
| Bendamustine for the first-line treatment of chronic lymphocytic leukaemia | TA216 | | |
| Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer | TA214 | | |
| Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices | IPG380 | | |
| Food allergy in under 19s: assessment and diagnosis | CG116 | | |
| Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years | TA213 | | |
| Percutaneous laser coronary angioplasty | IPG378 | | |
| Off-pump coronary artery bypass grafting | IPG377 | | |
| Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome | IPG376 | | |
| Thoracoscopic repair of congenital diaphragmatic hernia in neonates | IPG379 | | |
| Distal iliotibial band lengthening for refractory greater trochanteric pain syndrome | IPG375 | | |
| Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer | TA212 | | |
| Prucalopride for the treatment of chronic constipation in women | TA211 | | |
| Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events | TA210 | | |
| Selective dorsal rhizotomy for spasticity in cerebral palsy | IPG373 | | |
| Percutaneous radiofrequency ablation for primary or secondary lung cancers | IPG372 | | |
| Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers | IPG371 | | |
| Percutaneous closure of patent foramen ovale for recurrent migraine | IPG370 | | |
| Cryotherapy for the treatment of liver metastases | IPG369 | | |
| Sedation in under 19s: using sedation for diagnostic and therapeutic procedures | CG112 | | |
| Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours | TA209 | | |
| Trastuzumab for the treatment of HER2-positive metastatic gastric cancer | TA208 | | |
| Unintentional injuries on the road: interventions for under 15s | PH31 | | |
| Unintentional injuries in the home: interventions for under 15s | PH30 | | |
| Unintentional injuries: prevention strategies for under 15s | PH29 | | |
| Interspinous distraction procedures for lumbar spinal stenosis causing neurogenic claudication | IPG365 | | |
| Uterine artery embolisation for fibroids | IPG367 | | |
| Non-rigid stabilisation techniques for the treatment of low back pain | IPG366 | | |
| Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours | TA86 | | |
| Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) | TA207 | | |
| Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal) | TA206 | | |
| Denosumab for the prevention of osteoporotic fractures in postmenopausal women | TA204 | | |
| Transperineal template biopsy and mapping of the prostate | IPG364 | | |
| Minimally invasive total hip replacement | IPG363 | | |
| Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome | IPG362 | | |
| Insertion of metal rib reinforcements to stabilise a flail chest wall | IPG361 | | |
| Endoscopic submucosal dissection of gastric lesions | IPG360 | | |
| Endoscopic mucosal resection and endoscopic submucosal dissection of non-ampullary duodenal lesions | IPG359 | | |
| Bedwetting in under 19s | CG111 | | |
| Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C | TA200 | | |
| Percutaneous intradiscal laser ablation in the lumbar spine | IPG357 | | |
| Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer | IPG356 | | |
| Phototherapeutic laser keratectomy for corneal surface irregularities | IPG358 | | |
| Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia | IPG355 | | |
| Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors | CG110 | | |
| Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis | TA199 | | |
| Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor | TA195 | | |
| Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia | TA193 | | |
| Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer | TA192 | | |
| Capecitabine for the treatment of advanced gastric cancer | TA191 | | |
| Weight management before, during and after pregnancy | PH27 | | |
| Shoulder resurfacing arthroplasty | IPG354 | | |
| Percutaneous radiofrequency ablation for renal cancer | IPG353 | | |
| Percutaneous mitral valve annuloplasty | IPG352 | | |
| Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism | IPG349 | | |
| Stapled transanal rectal resection for obstructed defaecation syndrome | IPG351 | | |
| Photodynamic therapy for Barrett's oesophagus | IPG350 | | |
| Cardiovascular disease prevention | PH25 | | |
| Alcohol-use disorders: prevention | PH24 | | |
| Human growth hormone (somatropin) for the treatment of growth failure in children | TA188 | | |
| Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injury | IPG347 | | |
| Mini-incision surgery for total knee replacement | IPG345 | | |
| Epithelial radiofrequency ablation for Barrett's oesophagus | IPG344 | | |
| Improving outcomes for people with skin tumours including melanoma | CSG8 | | |
| Infliximab and adalimumab for the treatment of Crohn's disease | TA187 | | |
| Limited macular translocation for wet age-related macular degeneration | IPG339 | | |
| Haemorrhoidal artery ligation | IPG342 | | |
| Prosthetic intervertebral disc replacement in the cervical spine | IPG341 | | |
| Macular translocation with 360° retinotomy for wet age-related macular degeneration | IPG340 | | |
| Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions | IPG337 | | |
| Transcatheter endovascular closure of perimembranous ventricular septal defect | IPG336 | | |
| Endoscopic submucosal dissection of lower gastrointestinal lesions | IPG335 | | |
| Arteriovenous crossing sheathotomy for branch retinal vein occlusion | IPG334 | | |
| Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes | TA47 | | |
| Therapeutic endoscopic division of epidural adhesions | IPG333 | | |
| Donor milk banks: service operation | CG93 | | |
| Laparoscopic augmentation cystoplasty (including clam cystoplasty) | IPG326 | | |
| Endopyelotomy for pelviureteric junction obstruction | IPG325 | | |
| Electrocautery cutting balloon treatment for pelviureteric junction obstruction | IPG324 | | |
| Balloon catheter insertion for Bartholin's cyst or abscess | IPG323 | | |
| Suction diathermy adenoidectomy | IPG328 | | |
| Radiofrequency ablation for colorectal liver metastases | IPG327 | | |
| Topotecan for the treatment of relapsed small-cell lung cancer | TA184 | | |
| Topotecan for the treatment of recurrent and stage IVB cervical cancer | TA183 | | |
| Depression in adults with a chronic physical health problem: recognition and management | CG91 | | |
| Guidance on the use of electroconvulsive therapy | TA59 | | |
| Pemetrexed for the first-line treatment of non-small-cell lung cancer | TA181 | | |
| Sunitinib for the treatment of gastrointestinal stromal tumours | TA179 | | |
| Individually magnetic resonance imaging-designed unicompartmental interpositional implant insertion for osteoarthritis of the knee | IPG317 | | |
| Extracorporeal albumin dialysis for acute liver failure | IPG316 | | |
| Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma | TA178 | | |
| Alitretinoin for the treatment of severe chronic hand eczema | TA177 | | |
| Extracorporeal shockwave therapy for refractory plantar fasciitis | IPG311 | | |
| Placement of pectus bar for pectus excavatum (also known as MIRPE or the Nuss procedure) | IPG310 | | |
| Extracorporeal shockwave therapy for refractory tennis elbow | IPG313 | | |
| Rituximab for the first-line treatment of chronic lymphocytic leukaemia | TA174 | | |
| Tenofovir disoproxil for the treatment of chronic hepatitis B | TA173 | | |
| Image-guided radiofrequency excision biopsy of breast lesions | IPG308 | | |
| Prosthetic intervertebral disc replacement in the lumbar spine | IPG306 | | |
| Sinus tarsi implant insertion for mobile flatfoot | IPG305 | | |
| Corneal endothelial transplantation | IPG304 | | |
| Percutaneous endoscopic laser cervical discectomy | IPG303 | | |
| Percutaneous laser revascularisation for refractory angina pectoris | IPG302 | | |
| Transmyocardial laser revascularisation for refractory angina pectoris | IPG301 | | |
| Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) | IPG299 | | |
| Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults | TA170 | | |
| Ex-vivo hepatic resection and reimplantation for liver cancer | IPG298 | | |
| Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD) | IPG297 | | |
| Endoscopic mastectomy and endoscopic wide local excision for breast cancer | IPG296 | | |
| Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management | CG84 | | |
| Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation | IPG294 | | |
| Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia | IPG295 | | |
| Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma | TA169 | | |
| Implantation of an opaque intraocular lens for intractable double vision | IPG293 | | |
| Photodynamic therapy for brain tumours | IPG290 | | |
| Rehabilitation after critical illness in adults | CG83 | | |
| Amantadine, oseltamivir and zanamivir for the treatment of influenza | TA168 | | |
| Intraocular lens insertion for correction of refractive error, with preservation of the natural lens | IPG289 | | |
| Extracorporeal photopheresis for Crohn's disease | IPG288 | | |
| Laparoscopic cystectomy | IPG287 | | |
| Machine perfusion systems and cold static storage of kidneys from deceased donors | TA165 | | |
| Physical activity for children and young people | PH17 | | |
| Ultrasound-guided regional nerve block | IPG285 | | |
| Functional electrical stimulation for drop foot of central neurological origin | IPG278 | | |
| Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation | IPG286 | | |
| Borderline personality disorder: recognition and management | CG78 | | |
| Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence | CG76 | | |
| Infliximab for acute exacerbations of ulcerative colitis | TA163 | | |
| Transabdominal artificial bowel sphincter implantation for faecal incontinence | IPG276 | | |
| Laparoscopic prostatectomy for benign prostatic obstruction | IPG275 | | |
| Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin | TA159 | | |
| Mental wellbeing in over 65s: occupational therapy and physical activity interventions | PH16 | | |
| Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza | TA158 | | |
| Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults | TA157 | | |
| Cardiovascular disease: identifying and supporting people most at risk of dying early | PH15 | | |
| Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy | IPG274 | | |
| Balloon catheter dilation of paranasal sinus ostia for chronic sinusitis | IPG273 | | |
| Routine antenatal anti-D prophylaxis for women who are rhesus D negative | TA156 | | |
| Telbivudine for the treatment of chronic hepatitis B | TA154 | | |
| Entecavir for the treatment of chronic hepatitis B | TA153 | | |
| Total wrist replacement | IPG271 | | |
| Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus | TA151 | | |
| Laparoscopic gastrectomy for cancer | IPG269 | | |
| Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision | IPG268 | | |
| Direct skeletal fixation of limb or digit prostheses using intraosseous transcutaneous implants | IPG270 | | |
| Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal) | TA149 | | |
| Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal) | TA148 | | |
| Adalimumab for the treatment of adults with psoriasis | TA146 | | |
| Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck | TA145 | | |
| Implantation of multifocal (non-accommodative) intraocular lenses during cataract surgery | IPG264 | | |
| Lumbar infusion test for the investigation of normal pressure hydrocephalus | IPG263 | | |
| Physical activity in the workplace | PH13 | | |
| Endoaortic balloon occlusion for cardiac surgery | IPG261 | | |
| Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy | IPG258 | | |
| Interstitial photodynamic therapy for malignant parotid tumours | IPG259 | | |
| Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus | IPG257 | | |
| Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over | TA138 | | |
| Intraoperative nerve monitoring during thyroid surgery | IPG255 | | |
| Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma | TA137 | | |
| Structural neuroimaging in first-episode psychosis | TA136 | | |
| Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses | IPG254 | | |
| Laparoscopic mobilisation of the greater omentum for breast reconstruction | IPG253 | | |
| Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion | IPG252 | | |
| Pemetrexed for the treatment of malignant pleural mesothelioma | TA135 | | |
| Infliximab for the treatment of adults with psoriasis | TA134 | | |
| Ultrasound-guided catheterisation of the epidural space | IPG249 | | |
| Thoracoscopically assisted mitral valve surgery | IPG245 | | |
| Thoracoscopic aortopexy for severe primary tracheomalacia | IPG243 | | |
| Thoracoscopic excision of mediastinal parathyroid tumours | IPG247 | | |
| Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates | IPG246 | | |
| Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years | TA131 | | |
| Soft-palate implants for obstructive sleep apnoea | IPG241 | | |
| Soft-palate implants for simple snoring | IPG240 | | |
| Laparoscopic techniques for hysterectomy | IPG239 | | |
| Mini/micro screw implantation for orthodontic anchorage | IPG238 | | |
| Grenz rays therapy for inflammatory skin conditions | IPG236 | | |
| Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain | IPG234 | | |
| Behaviour change: general approaches | PH6 | | |
| Bortezomib monotherapy for relapsed multiple myeloma | TA129 | | |
| Stapled haemorrhoidopexy for the treatment of haemorrhoids | TA128 | | |
| Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children | IPG232 | | |
| Pemetrexed for the treatment of non-small-cell lung cancer | TA124 | | |
| Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis | IPG230 | | |
| Laparoscopic repair of abdominal aortic aneurysm | IPG229 | | |
| Therapeutic percutaneous image-guided aspiration of spinal cysts | IPG223 | | |
| Varenicline for smoking cessation | TA123 | | |
| Corneal implants for keratoconus | IPG227 | | |
| Laparoscopic deroofing of simple renal cysts | IPG226 | | |
| Corneal implants for the correction of refractive error | IPG225 | | |
| Drug misuse in over 16s: psychosocial interventions | CG51 | | |
| Drug misuse in over 16s: opioid detoxification | CG52 | | |
| Acutely ill adults in hospital: recognising and responding to deterioration | CG50 | | |
| Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma | TA121 | | |
| Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease | IPG222 | | |
| Faecal incontinence in adults: management | CG49 | | |
| Lower limb deep vein valve reconstruction for chronic deep venous incompetence | IPG219 | | |
| Therapeutic sialendoscopy | IPG218 | | |
| Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epithelium | IPG216 | | |
| Microwave ablation of hepatocellular carcinoma | IPG214 | | |
| Laparoscopic nephrolithotomy and pyelolithotomy | IPG212 | | |
| Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia | TA119 | | |
| Injectable bulking agents for faecal incontinence | IPG210 | | |
| Implantation of accommodating intraocular lenses for cataract | IPG209 | | |
| Laparoscopic insertion of peritoneal dialysis catheter | IPG208 | | |
| Radiofrequency-assisted liver resection | IPG211 | | |
| Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy | TA117 | | |
| Gemcitabine for the treatment of metastatic breast cancer | TA116 | | |
| Naltrexone for the management of opioid dependence | TA115 | | |
| Methadone and buprenorphine for the management of opioid dependence | TA114 | | |
| Palliative photodynamic therapy for advanced oesophageal cancer | IPG206 | | |
| Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction | IPG205 | | |
| Laparoscopic distal pancreatectomy | IPG204 | | |
| Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome | IPG199 | | |
| Intrauterine laser ablation of placental vessels for the treatment of twin-to-twin transfusion syndrome | IPG198 | | |
| Fetal vesico–amniotic shunt for lower urinary tract outflow obstruction | IPG202 | | |
| Photodynamic therapy for early-stage oesophageal cancer | IPG200 | | |
| Laparoscopic radical prostatectomy | IPG193 | | |
| Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) | IPG192 | | |
| Insertion of pleuro–amniotic shunt for fetal pleural effusion | IPG190 | | |
| Laparoscopic surgery for colorectal cancer | TA105 | | |
| Deep brain stimulation for tremor and dystonia (excluding Parkinson's disease) | IPG188 | | |
| Etanercept and efalizumab for the treatment of adults with psoriasis | TA103 | | |
| Catheterless oesophageal pH monitoring | IPG187 | | |
| Tonsillectomy using laser | IPG186 | | |
| High-intensity focused ultrasound for atrial fibrillation in association with other cardiac surgery | IPG184 | | |
| Docetaxel for the treatment of hormone-refractory metastatic prostate cancer | TA101 | | |
| Percutaneous laser therapy for fetal tumours | IPG180 | | |
| Percutaneous cementoplasty for palliative treatment of bony malignancies | IPG179 | | |
| Tonsillectomy using ultrasonic scalpel | IPG178 | | |
| Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery | IPG177 | | |
| Improving outcomes for people with brain and other central nervous system tumours | CSG10 | | |
| Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum | IPG176 | | |
| High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer | IPG174 | | |
| Laparoscopic helium plasma coagulation for the treatment of endometriosis | IPG171 | | |
| Living-donor lung transplantation for end-stage lung disease | IPG170 | | |
| Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer | TA100 | | |
| Percutaneous radiofrequency ablation for atrial fibrillation | IPG168 | | |
| Retrograde urethral sphincterometry | IPG167 | | |
| Balloon kyphoplasty for vertebral compression fractures | IPG166 | | |
| Photorefractive (laser) surgery for the correction of refractive errors | IPG164 | | |
| Stent-graft placement in abdominal aortic aneurysm | IPG163 | | |
| Percutaneous endoscopic colostomy | IPG161 | | |
| High dose rate brachytherapy for carcinoma of the cervix | IPG160 | | |
| Stimulated graciloplasty for faecal incontinence | IPG159 | | |
| Laparoscopic retroperitoneal lymph node dissection for testicular cancer | IPG158 | | |
| Endometrial cryotherapy for menorrhagia | IPG157 | | |
| Improving outcomes for people with sarcoma | CSG9 | | |
| Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B | TA96 | | |
| Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) | IPG155 | | |
| Image-guided vacuum-assisted excision biopsy of benign breast lesions | IPG156 | | |
| Foker technique for long-gap oesophageal atresia | IPG153 | | |
| Laparoscopic partial nephrectomy | IPG151 | | |
| Electrosurgery (diathermy and coblation) for tonsillectomy | IPG150 | | |
| Division of ankyloglossia (tongue-tie) for breastfeeding | IPG149 | | |
| Retrobulbar irradiation for thyroid eye disease | IPG148 | | |
| Endoscopic axillary lymph node retrieval for breast cancer | IPG147 | | |
| Direct C1 lateral mass screw for cervical spine stabilisation | IPG146 | | |
| Obsessive-compulsive disorder and body dysmorphic disorder: treatment | CG31 | | |
| Cryotherapy as a primary treatment for prostate cancer | IPG145 | | |
| Intraoperative blood cell salvage in obstetrics | IPG144 | | |
| Cryotherapy for malignant endobronchial obstruction | IPG142 | | |
| Automated percutaneous mechanical lumbar discectomy | IPG141 | | |
| Metatarsophalangeal joint replacement of the hallux | IPG140 | | |
| Intramural urethral bulking procedures for stress urinary incontinence in women | IPG138 | | |
| Photodynamic therapy for localised inoperable endobronchial cancer | IPG137 | | |
| Laparoscopic nephrectomy (including nephroureterectomy) | IPG136 | | |
| Improving outcomes in children and young people with cancer | CSG7 | | |
| HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries) | TA92 | | |
| Laparoscopic liver resection | IPG135 | | |
| Photodynamic therapy for bile duct cancer | IPG134 | | |
| Low dose rate brachytherapy for localised prostate cancer | IPG132 | | |
| Endovascular stent–graft placement in thoracic aortic aneurysms and dissections | IPG127 | | |
| Leukapheresis for inflammatory bowel disease | IPG126 | | |
| Interstitial laser therapy for fibroadenomas of the breast | IPG131 | | |
| Collagen injection for vocal cord augmentation | IPG130 | | |
| Computed tomographic colonography (virtual colonoscopy) | IPG129 | | |
| Totally endoscopic robotically assisted coronary artery bypass grafting | IPG128 | | |
| Cryoablation for atrial fibrillation in association with other cardiac surgery | IPG123 | | |
| Microwave ablation for atrial fibrillation in association with other cardiac surgery | IPG122 | | |
| Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery | IPG121 | | |
| Cryotherapy for recurrent prostate cancer | IPG119 | | |
| Guidance on the use of paclitaxel in the treatment of ovarian cancer | TA55 | | |
| High-intensity focused ultrasound for prostate cancer | IPG118 | | |
| Lung volume reduction surgery for advanced emphysema | IPG114 | | |
| Endoscopic dacryocystorhinostomy | IPG113 | | |
| Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis | IPG111 | | |
| Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis | IPG110 | | |
| Auditory brain stem implants | IPG108 | | |
| Coil embolisation of ruptured intracranial aneurysms | IPG106 | | |
| Coil embolisation of unruptured intracranial aneurysms | IPG105 | | |
| Wireless capsule endoscopy for investigation of the small bowel | IPG101 | | |
| Sacral nerve stimulation for faecal incontinence | IPG99 | | |
| Improving outcomes in head and neck cancers | CSG6 | | |
| Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency | IPG98 | | |
| Endovascular closure of patent ductus arteriosus | IPG97 | | |
| Endovascular closure of atrial septal defect | IPG96 | | |
| Radiofrequency valvotomy for pulmonary atresia | IPG95 | | |
| Laparoscopic surgery for inguinal hernia repair | TA83 | | |
| Intralesional photocoagulation of subcutaneous congenital vascular disorders | IPG90 | | |
| Interstitial laser therapy for breast cancer | IPG89 | | |
| Tacrolimus and pimecrolimus for atopic eczema | TA82 | | |
| Frequency of application of topical corticosteroids for atopic eczema | TA81 | | |
| Photodynamic therapy for advanced bronchial carcinoma | IPG87 | | |
| Endovascular atrial septostomy | IPG86 | | |
| Supraorbital minicraniotomy for intracranial aneurysm | IPG84 | | |
| Selective peripheral denervation for cervical dystonia | IPG80 | | |
| Balloon dilatation of systemic to pulmonary arterial shunts in children | IPG77 | | |
| Balloon valvuloplasty for aortic valve stenosis in adults and children | IPG78 | | |
| Stent placement for vena caval obstruction | IPG79 | | |
| Balloon angioplasty of pulmonary vein stenosis in infants | IPG75 | | |
| Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children | IPG76 | | |
| Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children | IPG74 | | |
| Fallopian tube recanalisation by guidewire | IPG71 | | |
| Scleral expansion surgery for presbyopia | IPG70 | | |
| Insertion of hydrogel keratoprosthesis | IPG69 | | |
| Lumbar subcutaneous shunt | IPG68 | | |
| Subthalamotomy for Parkinson's disease | IPG65 | | |
| Artificial anal sphincter implantation | IPG66 | | |
| Laser sheath removal of pacing leads | IPG63 | | |
| Balloon dilatation of pulmonary valve stenosis | IPG67 | | |
| Sacral nerve stimulation for urge incontinence and urgency-frequency | IPG64 | | |
| Falloposcopy with coaxial catheter | IPG62 | | |
| Laparoscopic live donor simple nephrectomy | IPG57 | | |
| Thrombin injections for pseudoaneurysms | IPG60 | | |
| Transpupillary thermotherapy for age-related macular degeneration | IPG58 | | |
| Percutaneous endoscopic laser thoracic discectomy | IPG61 | | |
| Subfascial endoscopic perforator vein surgery | IPG59 | | |
| Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding | TA78 | | |
| Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia | TA77 | | |
| Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) | IPG56 | | |
| Endoscopic injection of bulking agents for gastro-oesophageal reflux disease | IPG55 | | |
| Endovenous laser treatment of the long saphenous vein | IPG52 | | |
| Vagus nerve stimulation for refractory epilepsy in children | IPG50 | | |
| Computed tomography-guided thermocoagulation of osteoid osteoma | IPG53 | | |
| Radiotherapy for age-related macular degeneration | IPG49 | | |
| Laparoscopic pyeloplasty | IPG46 | | |
| Photodynamic endometrial ablation | IPG47 | | |
| Improving supportive and palliative care for adults with cancer | CSG4 | | |
| Partial left ventriculectomy (the Batista procedure) | IPG41 | | |
| Needle fasciotomy for Dupuytren's contracture | IPG43 | | |
| Non-surgical reduction of the myocardial septum | IPG40 | | |
| Cyanoacrylate instillation for occlusion of parotid sinuses | IPG42 | | |
| Pre-hospital initiation of fluid replacement therapy in trauma | TA74 | | |
| Extracorporeal membrane oxygenation (ECMO) in postneonatal children | IPG38 | | |
| Transilluminated powered phlebectomy for varicose veins | IPG37 | | |
| Endoscopic transsphenoidal pituitary adenoma resection | IPG32 | | |
| Circular stapled haemorrhoidectomy | IPG34 | | |
| Endoscopic laser foraminoplasty | IPG31 | | |
| Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids | IPG30 | | |
| Extracorporeal shockwave therapy for Peyronie's disease | IPG29 | | |
| Laparo-endogastric surgery | IPG25 | | |
| Laparoscopic laser myomectomy | IPG23 | | |
| Endoscopic stapling of pharyngeal pouch | IPG22 | | |
| Bone-anchored cystourethropexy | IPG18 | | |
| Deep brain stimulation for Parkinson's disease | IPG19 | | |
| Holmium laser prostatectomy | IPG17 | | |
| Guidance on the use of liquid-based cytology for cervical screening | TA69 | | |
| Transurethral electrovaporisation of the prostate | IPG14 | | |
| Radiofrequency ablation of varicose veins | IPG8 | | |
| Percutaneous vertebroplasty | IPG12 | | |
| Human growth hormone (somatropin) in adults with growth hormone deficiency | TA64 | | |
| Radiofrequency ablation of hepatocellular carcinoma | IPG2 | | |
| Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer | TA61 | | |
| Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction | TA52 | | |
| Guidance on the use of ultrasound locating devices for placing central venous catheters | TA49 | | |
| Improving outcomes in urological cancers | CSG2 | | |
| Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years) | TA38 | | |
| Guidance on the use of trastuzumab for the treatment of advanced breast cancer | TA34 | | |
| Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia | TA29 | | |
| Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease | TA20 | | |
| Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma | TA10 | | |
| Guidance on the extraction of wisdom teeth | TA1 | | |